Postmenopausal osteoporosis with pathological fracture

OSTPOPATFRCTURE_POSTEMENO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M80.0 Cause of death: ICD-10 — M80.0 2 out of 7 registries used, show all original rules.	2855
4. Check minimum number of events None	2855
5. Include endpoints None	2855
6. Filter based on genotype QC (FinnGen only)	2560

Control definitions (FinnGen only)

Control exclude: OSTEOPOROSIS_FRACTURE_FG

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M80
Name in latin: Osteoporosis postmenopausalis cum fractura pathologica

NAME	OSTPOPATFRCTURE_POSTEMENO
CONTROL_EXCLUDE	OSTEOPOROSIS_FRACTURE_FG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M800
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M800
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Postmenopausal osteoporosis with pathological fracture based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19351	19351	-
Only index persons	17522	17522	-
Unadjusted period prevalence (%)
Whole population	0.55	0.55	-
Only index persons	0.64	0.64	-
Median age at first event (years)
Whole population	-	79.64	-
Only index persons	-	79.50	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2560	2560	-
Unadjusted period prevalence (%)	0.91	0.91	-
Median age at first event (years)	74.83	74.83	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2640: Matched controls
26400

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

10.3

307.7

521

613

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.2

307.7

2168

11279

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.5

307.7

866

2135

H05AA02

ATC

teriparatide; parenteral

84.4

307.7

259

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

15.2

307.7

497

398

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

+∞

307.7

2640

280

M81.9

ICD-10 Finland

Osteoporosis, unspecified

7.4

307.7

770

1392

318

Kela drug reimbursment

Teriparatide

84.9

307.7

281

M05BX04

ATC

denosumab; parenteral

11.4

307.7

1186

1768

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

11.3

307.7

378

386

L95

ICPC

Osteoporosis

9.5

307.7

806

1168

M05BA04

ATC

alendronic acid; oral

6.2

307.7

1206

3161

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

6.7

306.3

564

1033

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.7

295.4

670

1492

M05BA07

ATC

risedronic acid; oral

6.1

256.9

513

1008

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

9.9

242.2

292

326

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

228.2

1150

4571

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.7

224.5

1682

8564

M80

ICD-10 Finland

Osteoporosis with pathological fracture

11.9

190.6

199

180

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.7

179.7

307

511

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.8

166.4

425

1018

M54.5

ICD-10 Finland

Low back pain

3.0

162.4

1432

7538

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

28.3

156.7

106

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

141.8

1057

4999

X59

ICD-10 Finland

Exposure to unspecified factor

3.1

137.2

787

3219

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

8.7

128.8

168

205

N02AA05

ATC

oxycodone; systemic

2.7

126.2

972

4622

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.9

123.2

294

660

M05BA06

ATC

ibandronic acid; systemic

5.1

120.4

269

571

L76

ICPC

Fracture: other

4.7

118.2

293

678

L03

ICPC

Low back symptom/complaint

2.4

100.0

1128

6272

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

207.8

97.1

100

N02AX02

ATC

tramadol; systemic, rectal

2.3

95.4

1454

9137

M05BX03

ATC

strontium ranelate; oral

8.4

95.2

126

156

S72.0

ICD-10 Finland

Fracture of neck of femur

3.5

90.4

350

1110

N03AX12

ATC

[U] gabapentin; oral

2.5

88.2

702

3300

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.2

80.8

229

584

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.8

79.7

460

1834

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.8

79.3

479

1955

NA2AD

NOMESCO Finland

Thoracic spine CT examination

10.8

75.4

W19

ICD-10 Finland

Unspecified fall

2.7

74.3

476

1997

A28

ICPC

Limited function/disability NOS

2.2

74.1

990

5735

N03AX16

ATC

[U] pregabalin

2.2

73.2

901

5049

S52.5

ICD-10 Finland

Fracture of lower end of radius

2.5

72.8

594

2796

L28

ICPC

Limited function/disability (L)

2.1

71.9

972

5642

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

6.7

70.9

115

179

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

14.7

69.1

SPAT1254

SPAT

Administration of medicine

2.2

65.4

683

3557

S22.3

ICD-10 Finland

Fracture of rib

3.2

64.9

284

964

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

61.9

1249

8262

SPAT1229

SPAT

Assessment of need for aid

2.5

60.7

431

1889

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.4

60.7

481

2218

NF1AA

NOMESCO Finland

Hip X-ray examination

2.4

59.7

503

2382

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

58.5

1591

11553

M05BX06

ATC

romosozumab; parenteral

75.3

58.3

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.6

58.1

379

1592

X58

ICD-10 Finland

Exposure to other specified factors

2.5

58.0

439

1979

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

57.4

386

1645

AA1AD

NOMESCO Finland

CT of head and brain

1.9

56.8

1127

7349

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.7

56.7

189

539

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.7

56.0

329

1311

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

55.9

1351

9381

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

55.7

1048

6703

A06AD11

ATC

lactulose; oral

2.1

55.3

681

3748

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

55.2

745

4243

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

55.1

585

3040

L02

ICPC

Back symptom/complaint

2.5

54.5

389

1704

NF3AA

NOMESCO Finland

Femur X-ray examination

4.0

53.7

161

426

M54.6

ICD-10 Finland

Pain in thoracic spine

2.8

53.6

285

1076

M81.5

ICD-10 Finland

Idiopathic osteoporosis

6.0

53.6

165

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.1

53.2

153

393

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

53.1

482

2346

WX212

NOMESCO Finland

Femoral plexus blockade

3.6

53.0

182

529

ZXD05

NOMESCO Finland

Urgent procedure

2.0

53.0

875

5336

C03CA01

ATC

furosemide; systemic

1.9

52.2

1334

9355

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.8

51.9

119

256

3079, ,

Kela drug reimbursment

137.8

51.0

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

7.4

50.9

102

M48.0

ICD-10 Finland

Spinal stenosis

2.1

50.6

577

3073

5BA08, ,

NOMESCO Finland

9.5

49.0

N02BE01

ATC

paracetamol; systemic, rectal

4.3

48.4

2548

22841

WVA30, ,

SPAT

2.8

47.9

267

1032

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

47.8

869

5434

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.2

44.2

423

2092

H02AB06

ATC

prednisolone; systemic

1.8

44.1

1419

10462

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

4.7

43.8

104

230

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

43.6

182

598

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.4

43.2

160

488

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

43.1

1252

8944

WVA20, ,

SPAT

3.3

43.0

168

530

N06AX21

ATC

duloxetine; oral

2.2

42.5

437

2223

A02BC02

ATC

pantoprazole; systemic

1.9

42.1

2046

16936

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

42.0

693

4167

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

10.6

42.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

41.6

1127

7866

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.8

41.2

219

824

SPAT1216

SPAT

Assessment of functional ability

1.9

41.0

710

4331

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

40.6

674

4055

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

40.5

577

3299

S97

ICPC

Chronic ulcer skin

2.5

39.6

280

1213

L04AX01

ATC

azathioprine; systemic

3.3

39.1

150

468

M81.8

ICD-10 Finland

Other osteoporosis

4.8

38.9

187

N02BF01

ATC

gabapentin; oral

2.2

38.6

392

1979

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

38.5

268

1152

L75

ICPC

Fracture: femur

3.8

38.2

120

328

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

6.0

37.8

114

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

37.3

436

2319

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

37.2

445

2386

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

6.5

36.7

H02AB09

ATC

hydrocortisone; systemic

4.1

36.7

104

264

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

36.3

995

6896

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.7

35.9

207

811

L84

ICPC

Back syndrome without radiat pain

2.7

35.9

210

829

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

35.8

523

3002

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

35.8

402

2104

R53

ICD-10 Finland

Malaise and fatigue

1.7

35.7

879

5908

R03BB04

ATC

tiotropium bromide; inhalant

2.2

35.7

315

1500

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

6.0

35.6

107

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.2

35.5

146

475

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

35.4

353

1766

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

35.2

226

934

M40.1

ICD-10 Finland

Other secondary kyphosis

14.1

34.8

A01

ICPC

Pain general/multiple sites

2.0

34.8

437

2381

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

34.8

442

2418

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

34.4

419

2256

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

34.4

714

4566

SPAT1263

SPAT

Sampling

1.7

34.1

1253

9333

ZX120

NOMESCO Finland

Intravenous

2.2

33.9

313

1518

N30.0

ICD-10 Finland

Acute cystitis

1.7

33.7

768

5036

SPAT1301

SPAT

No procedures

1.7

33.6

1046

7459

S72.2

ICD-10 Finland

Subtrochanteric fracture

5.2

33.6

135

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

33.5

554

3303

S32.1

ICD-10 Finland

Fracture of sacrum

5.3

33.5

128

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.0

33.3

S22.1

ICD-10 Finland

Multiple fractures of thoracic spine

12.9

33.2

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

33.0

324

1608

L86

ICPC

Back syndrome with radiating pain

2.4

33.0

252

1127

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.4

32.9

251

1122

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

7.9

32.8

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.6

32.5

198

797

J01MA02

ATC

ciprofloxacin; systemic

1.6

32.2

1122

8205

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

31.8

212

891

B01AB05

ATC

enoxaparin; parenteral

1.6

31.8

1058

7645

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

31.7

433

2422

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

31.7

349

1809

WX704

NOMESCO Finland

Intubation

2.3

30.9

255

1179

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

30.9

157

576

M54

ICD-10 Finland

Dorsalgia

2.0

30.9

366

1948

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

30.8

392

2138

E21.0

ICD-10 Finland

Primary hyperparathyroidism

3.3

30.3

119

376

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

30.0

676

4397

L17

ICPC

Foot/toe symptom/complaint

1.6

30.0

977

6995

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

29.5

293

1459

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.4

29.5

110

337

N02BF02

ATC

pregabalin; oral

2.3

29.3

246

1144

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

29.2

390

2161

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

28.7

504

3045

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

28.0

181

749

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.9

28.0

138

498

M54.8

ICD-10 Finland

Other dorsalgia

2.5

27.9

177

726

S52.0

ICD-10 Finland

Fracture of upper end of ulna

3.6

27.6

257

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

7.6

27.6

N06AX11

ATC

mirtazapine; oral

1.6

27.6

1068

7924

SPAT1255

SPAT

Intravenous administration of medicine

2.2

27.2

233

1093

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

3.3

27.1

102

314

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

27.0

618

4019

L04AX03

ATC

methotrexate; systemic

2.0

26.9

308

1614

J01FF01

ATC

clindamycin; systemic

1.7

26.9

729

4956

S70.0

ICD-10 Finland

Contusion of hip

2.4

26.6

186

799

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

26.5

528

3304

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

26.4

436

2581

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.9

26.4

125

441

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

26.3

677

4537

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.0

26.3

116

393

M05BA01

ATC

etidronic acid; systemic

4.5

26.2

145

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.3

26.2

100

311

A04

ICPC

Weakness/tiredness general

1.7

26.0

584

3775

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

25.9

165

678

J01DB01

ATC

cefalexin; oral

1.7

25.9

2146

18884

S72.3

ICD-10 Finland

Fracture of shaft of femur

4.3

25.8

155

L88

ICPC

Rheumatoid/seropositive arthritis

2.5

25.8

174

735

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.6

25.6

151

598

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.0

25.5

113

384

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

25.3

242

1186

ZZH40

NOMESCO Finland

Substitute of bone

4.7

25.3

125

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

25.2

978

7219

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

25.2

176

755

SPAT1260

SPAT

Consultation of another employee

1.7

25.0

569

3685

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

25.0

190

846

A29

ICPC

General symptom/complaint other

1.7

24.9

490

3049

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.6

24.8

146

577

UJF32

NOMESCO Finland

Coloscopy

1.6

24.6

840

6016

M79.6

ICD-10 Finland

Pain in limb

1.5

24.4

1284

10108

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

5.7

24.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

24.3

279

1463

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

24.2

224

1082

R11

ICD-10 Finland

Nausea and vomiting

1.9

24.2

343

1931

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.1

24.1

105

353

J01EA01

ATC

trimethoprim; systemic

1.5

24.1

1038

7820

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.7

23.9

129

488

P01BA02

ATC

hydroxychloroquine; oral

1.9

23.7

303

1648

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

23.6

104

352

NA3AA, ,

SPAT

2.7

23.6

125

469

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.8

23.5

117

424

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

23.5

608

4064

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

23.4

270

1417

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

2.8

23.4

121

448

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

23.4

270

1418

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

23.3

311

1716

R60.0

ICD-10 Finland

Localized oedema

1.7

23.2

499

3177

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.4

23.1

258

WX320

NOMESCO Finland

Spinalanesthesy

1.6

23.1

759

5371

M03BX02

ATC

tizanidine; oral

1.5

23.0

1495

12240

W10

ICD-10 Finland

Fall on and from stairs and steps

2.2

22.9

192

891

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

22.9

221

1086

R33

ICD-10 Finland

Retention of urine

2.5

22.8

154

650

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.1

22.8

215

1046

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.0

22.7

101

344

UKC02

NOMESCO Finland

Cystoscopy

1.8

22.7

380

2253

Y94.0

ICD-10 Finland

Accident at home

3.0

22.6

101

345

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

22.6

240

1222

S20.2

ICD-10 Finland

Contusion of thorax

2.4

22.6

162

703

327

Kela drug reimbursment

strontium ranelate

23.1

22.6

J01MA12

ATC

levofloxacin; systemic

1.7

22.3

516

3347

ZX120, ,

SPAT

3.8

22.3

187

L05

ICPC

Flank/axilla symptom/complaint

2.1

22.3

221

1097

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.1

22.2

219

1084

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

7.6

22.1

W17

ICD-10 Finland

Other fall from one level to another

2.9

21.6

101

354

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

5.0

21.6

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

21.4

300

1680

R50.9

ICD-10 Finland

Fever, unspecified

1.8

21.3

383

2315

R4110, ,

SPAT

1.7

21.2

468

2993

NK6QA, ,

SPAT

4.1

21.2

148

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

21.2

493

3197

ZX112, ,

SPAT

5.3

21.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

21.0

259

1389

NC2AA

NOMESCO Finland

Forearm X-ray examination

3.7

20.8

182

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.5

20.6

129

526

S18

ICPC

Laceration/cut

1.5

20.6

1324

10719

NA2AA, ,

SPAT

5.1

20.5

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.4

20.4

137

577

Y94.8

ICD-10 Finland

Other leisure activity accident

2.9

20.4

349

S22.4

ICD-10 Finland

Multiple fractures of ribs

3.5

20.3

209

A02BC05

ATC

esomeprazole; systemic

1.5

20.3

1172

9281

N03AX09

ATC

lamotrigine; oral

2.9

20.3

350

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

20.2

982

7512

S01.0

ICD-10 Finland

Open wound of scalp

2.0

20.2

247

1322

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

20.2

151

668

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

20.0

225

1169

S32.5

ICD-10 Finland

Fracture of pubis

3.4

20.0

221

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

19.9

507

3360

SPAT1234

SPAT

Support of social functional capacity

1.9

19.6

248

1341

L01BA01

ATC

methotrexate; systemic

2.4

19.6

139

600

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

19.6

170

800

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

19.4

160

737

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

19.4

1410

11632

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

19.3

872

6558

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.3

19.2

115

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

19.2

554

3779

SPAT1172

SPAT

Guidance concerning hydration

2.4

19.0

135

583

XKD00

NOMESCO Finland

Uroflowmetry

2.2

19.0

168

797

A46

ICD-10 Finland

Erysipelas

1.7

19.0

446

2893

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

18.9

194

974

WX213

NOMESCO Finland

Lower leg blockade

5.3

18.9

Y96.9

ICD-10 Finland

Unspecified type of accident

3.3

18.9

224

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

18.9

114

457

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

18.8

155

715

JN4AD

NOMESCO Finland

Body CT examination

1.7

18.7

346

2103

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

18.7

166

788

WX720

NOMESCO Finland

Own respiration

2.3

18.7

149

677

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

18.7

337

2035

K07

ICPC

Swollen ankles/oedema

1.9

18.7

231

1240

347

Kela drug reimbursment

denosumab

21.0

18.6

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.2

18.5

154

713

T92.2

ICD-10 Finland

Sequelae of fracture at wrist and hand level

4.8

18.5

J47

ICD-10 Finland

Bronchiectasis

2.9

18.4

307

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

18.4

291

1690

E87.6

ICD-10 Finland

Hypokalaemia

2.2

18.3

154

716

E0000UV, ,

ATC

1.4

18.1

1157

9272

N87

ICPC

Parkinsonism

3.1

17.7

233

L13

ICPC

Hip symptom/complaint

1.5

17.7

711

5203

G04CA02

ATC

tamsulosin; oral

2.5

17.7

110

447

WX402

NOMESCO Finland

General anaesthesia

1.6

17.7

529

3631

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

17.6

1685

14505

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

17.6

292

1719

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.4

17.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

17.3

123

532

G20

ICD-10 Finland

Parkinson disease

2.4

17.2

123

533

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

17.2

164

802

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

3.2

17.0

218

M80.1

ICD-10 Finland

Postoophorectomy osteoporosis with pathological fracture

25.8

16.9

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

16.9

142

660

-50

ICPC

Medication/prescr/renewal

2.2

16.8

141

655

SPAT1310

SPAT

Counselling related to known health issue

1.4

16.7

876

6740

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

16.7

219

1198

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

16.7

356

2247

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.2

16.6

151

724

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

16.6

149

711

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

16.6

148

705

S82.1

ICD-10 Finland

Fracture of upper end of tibia

2.9

16.5

276

L11

ICPC

Wrist symptom/complaint

1.8

16.4

282

1676

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

16.4

663

4847

R06.0

ICD-10 Finland

Dyspnoea

1.4

16.3

852

6544

A07AA02

ATC

nystatin; oral

1.9

16.2

233

1312

SPAT1210

SPAT

Application of cast or individual aid

2.2

16.2

145

691

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

16.2

160

793

WX204

NOMESCO Finland

Axillary plexus blockaced

2.5

16.2

400

Z01.2

ICD-10 Finland

Dental examination

1.4

16.1

1069

8567

NA7LT

NOMESCO Finland

Percutaneous vertebroplasty

30.2

16.1

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.0

16.1

247

N05CF01

ATC

zopiclone; oral

1.4

16.1

1025

8159

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

16.0

228

1281

S06.0

ICD-10 Finland

Concussion

1.7

16.0

321

1993

WZA00

NOMESCO Finland

Concise certificate

2.0

15.9

168

852

SPAT1053

SPAT

Memory test

1.5

15.9

573

4085

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

15.8

354

2260

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

6.4

15.8

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.1

15.8

145

698

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

15.8

146

705

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.8

15.8

277

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

15.7

297

1813

NFJ50

NOMESCO Finland

Internal fixation of fracture of neck of femur with nail or screw

5.1

15.7

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

15.7

285

1721

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

15.7

170

871

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

15.7

207

1135

K59.0

ICD-10 Finland

Constipation

1.9

15.7

213

1179

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

4.6

15.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

15.6

236

1350

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

15.6

112

487

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

15.5

1519

12982

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

15.5

1187

9734

U04

ICPC

Incontinence urine

1.7

15.5

277

1666

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.7

15.4

326

N06AA09

ATC

amitriptyline; systemic

1.6

15.4

352

2259

E83.50

ICD-10 Finland

Hypercalcemia

2.9

15.4

253

B01AB10

ATC

tinzaparin; parenteral

1.7

15.4

325

2044

J01CA08

ATC

pivmecillinam; oral

1.4

15.4

1614

13950

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

15.3

286

1741

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

15.2

496

3460

R02

ICPC

Shortness of breath/dyspnoea

1.6

15.2

449

3065

SPAT1211

SPAT

Application of soft bandage

1.7

15.1

277

1676

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.2

15.1

S72.4

ICD-10 Finland

Fracture of lower end of femur

3.4

15.1

162

T89

ICPC

Diabetes insulin dependent

2.7

15.0

313

L29

ICPC

Musculoskeletal sympt/complt other

1.7

15.0

299

1853

B01AA03

ATC

warfarin; systemic

1.5

14.9

600

4371

L04AA06

ATC

mycophenolic acid; systemic

3.7

14.9

125

H02AA02

ATC

fludrocortisone; oral

4.0

14.9

107

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

14.8

1471

12558

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

14.8

125

583

M84.0

ICD-10 Finland

Malunion of fracture

4.9

14.7

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.1

14.7

TPH04, ,

SPAT

3.4

14.7

155

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

3.1

14.6

191

N05AH04

ATC

quetiapine; oral

1.6

14.6

408

2749

SPAT1153

SPAT

Removal of sutures

1.4

14.5

885

6956

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

14.5

338

2178

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.4

14.5

151

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.9

14.5

234

N04BD02

ATC

rasagiline; oral

4.4

14.5

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

14.5

439

3010

NB1AD

NOMESCO Finland

Shoulder CT examination

2.6

14.5

313

ZZH31

NOMESCO Finland

Bone allograft, small pieces

3.9

14.5

109

NAK40

NOMESCO Finland

Vertebroplasty

36.2

14.4

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

2.9

14.4

224

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.4

14.4

157

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.0

14.3

S82.0

ICD-10 Finland

Fracture of patella

2.7

14.3

292

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

14.3

903

7138

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

14.3

455

3155

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.8

14.2

253

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

3.2

14.2

173

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

12.0

14.1

H02AB07

ATC

prednisone; oral

1.6

14.0

401

2712

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

14.0

114

523

M43.1

ICD-10 Finland

Spondylolisthesis

2.0

14.0

144

724

W06

ICD-10 Finland

Fall involving bed

3.5

14.0

140

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

14.0

164

864

R1250, ,

SPAT

2.2

14.0

114

524

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.6

14.0

331

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

13.9

214

1230

M01AH05

ATC

etoricoxib; oral

1.4

13.9

1487

12786

N05BA01

ATC

diazepam; systemic, rectal

1.6

13.8

394

2664

WYA20, ,

SPAT

3.8

13.8

113

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

13.7

140

702

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

13.7

218

1267

L16

ICPC

Ankle symptom/complaint

1.6

13.7

331

2153

A02BC01

ATC

omeprazole; systemic

1.4

13.7

813

6350

ZXD35

NOMESCO Finland

Usual procedure

2.3

13.7

103

458

L04AA13

ATC

[U] leflunomide

2.5

13.6

359

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.3

13.6

427

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

13.6

124

596

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

13.5

118

557

N02AJ13

ATC

tramadol and paracetamol; systemic

2.5

13.5

342

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

13.5

194

1092

R03BA01

ATC

beclometasone; inhalant

1.5

13.5

404

2759

S42.0

ICD-10 Finland

Fracture of clavicle

2.6

13.5

295

B80

ICPC

Iron deficiency anaemia

2.4

13.5

385

M48.4

ICD-10 Finland

Fatigue fracture of vertebra

11.0

13.5

TKC22

NOMESCO Finland

Catheterisation instruction

3.5

13.5

129

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

13.5

404

R03AC02

ATC

salbutamol; inhalant

1.4

13.4

1380

11764

NCJ64

NOMESCO Finland

Other internal fixation of fracture of forearm

3.6

13.4

120

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

13.4

417

2873

ZXA00

NOMESCO Finland

Right side

1.4

13.4

822

6451

Y96.8

ICD-10 Finland

Other type of accident

4.9

13.3

N06AX26

ATC

vortioxetine; oral

1.9

13.3

171

930

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.8

13.3

107

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.0

13.2

192

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

13.2

176

969

L12

ICPC

Hand/finger symptom/complaint

1.5

13.1

463

3275

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

13.1

546

3993

A02BC03

ATC

lansoprazole; oral

1.4

13.1

843

6664

L04AB01

ATC

etanercept; parenteral

3.5

13.1

127

SPAT1325

SPAT

Vaccination

1.4

13.0

1006

8186

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

13.0

1176

9808

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

13.0

169

922

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.9

12.8

N06AX16

ATC

venlafaxine; oral

1.6

12.8

328

2161

SPAT1312

SPAT

General health counselling

1.4

12.8

810

6378

L73

ICPC

Fracture: tibia/fibula

3.0

12.8

190

R03BA05

ATC

fluticasone; inhalant

1.5

12.8

466

3318

R52.9

ICD-10 Finland

Pain, unspecified

1.6

12.8

296

1904

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

12.7

333

2204

M01AH02

ATC

rofecoxib; oral

1.5

12.7

440

3098

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

12.7

213

1256

M40.2

ICD-10 Finland

Other and unspecified kyphosis

9.7

12.7

ZXA10

NOMESCO Finland

Bilateral

1.4

12.7

591

4409

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

12.7

403

2788

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.5

12.6

317

L72

ICPC

Fracture: radius/ulna

2.2

12.6

101

461

ZXA05

NOMESCO Finland

Left side

1.4

12.6

755

5888

S42.4

ICD-10 Finland

Fracture of lower end of humerus

3.1

12.6

176

SPAT1167

SPAT

Insertion of urinary catheter

2.2

12.5

106

495

A02BA02

ATC

ranitidine; systemic

1.4

12.5

604

4536

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

12.5

212

1255

R03BB01

ATC

ipratropium bromide; inhalant

2.1

12.5

121

596

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.3

12.5

141

J46

ICD-10 Finland

Status asthmaticus

2.2

12.5

104

483

Z50.1

ICD-10 Finland

Other physical therapy

1.9

12.4

169

936

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.5

12.4

296

E10

ICD-10 Finland

Type 1 diabetes mellitus

4.0

12.4

NF3AD

NOMESCO Finland

Femur CT

5.4

12.3

R2130, ,

SPAT

3.1

12.3

168

NAJ32

NOMESCO Finland

Posterior reduction of fractrue of lumbar spine

10.5

12.2

NA7AD

NOMESCO Finland

Spine CT

9.7

12.2

H02AB04

ATC

methylprednisolone; systemic

1.5

12.2

407

2843

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

12.2

127

643

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

12.1

107

508

WVA20

NOMESCO Finland

Medicine administration

2.4

12.1

354

WX892

NOMESCO Finland

Monitored bed care

1.8

12.1

198

1159

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.2

12.1

105

495

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.4

12.1

355

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.9

12.0

186

N05BA04

ATC

oxazepam; oral

1.4

12.0

774

6101

H26.4

ICD-10 Finland

After-cataract

1.5

12.0

490

3563

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

12.0

319

WZC00, ,

SPAT

1.5

11.9

378

2611

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

11.9

125

634

N29

ICPC

Neurological sympt/complt other

2.7

11.9

249

OAB50, ,

SPAT

1.7

11.9

215

1296

U05

ICPC

Urination problems other

1.8

11.8

169

950

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

11.8

202

1198

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

5.9

11.8

N02AC04

ATC

dextropropoxyphene; oral

2.0

11.8

132

685

K02.1

ICD-10 Finland

Caries of dentine

1.3

11.7

1197

10112

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

11.7

383

2663

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.7

1032

8535

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.2

11.7

424

M01CB01

ATC

sodium aurothiomalate; parenteral

2.7

11.7

240

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

11.6

431

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

3.9

11.5

SPAT1262

SPAT

Handing over of treatment supplies

1.5

11.5

456

3293

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.4

11.5

313

Z2446

NOMESCO Finland

Social worker

1.8

11.5

162

907

C07AB07

ATC

bisoprolol; oral

1.3

11.5

1491

13026

S32.3

ICD-10 Finland

Fracture of ilium

8.6

11.5

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

2.5

11.5

283

R5110, ,

SPAT

1.5

11.5

330

2231

XQ855, ,

SPAT

3.1

11.5

159

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

3.8

11.5

NDJ62

NOMESCO Finland

Internal fixation of fracture of wrist or hand using plate and screws, schaphoid

2.9

11.4

186

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

11.4

320

R03AC12

ATC

salmeterol; inhalant

1.9

11.4

142

764

L10

ICPC

Elbow symptom/complaint

2.2

11.4

468

K92.1

ICD-10 Finland

Melaena

1.8

11.4

166

940

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.0

11.4

128

666

J96.1

ICD-10 Finland

Chronic respiratory failure

2.6

11.4

255

M81

ICD-10 Finland

Osteoporosis without pathological fracture

3.1

11.3

155

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.6

11.3

250

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.4

11.3

341

NG1AD

NOMESCO Finland

Knee CT examination

2.5

11.2

286

N18

ICPC

Paralysis/weakness

2.5

11.2

280

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.4

11.2

305

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

2.9

11.2

183

A08

ICPC

Swelling

1.7

11.2

227

1411

A01AB09

ATC

miconazole; local oral

1.6

11.2

303

2021

S52.2

ICD-10 Finland

Fracture of shaft of ulna

3.5

11.1

106

N04BC05

ATC

pramipexole; oral

1.6

11.0

262

1694

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

11.0

301

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

5.8

11.0

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.1

11.0

475

K90.0

ICD-10 Finland

Coeliac disease

2.2

10.9

390

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

4.7

10.9

M02AA10

ATC

ketoprofen; topical

1.4

10.9

493

3646

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.0

10.9

153

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

10.9

191

A07AA09

ATC

vancomycin; oral

2.8

10.9

191

R03DC03

ATC

montelukast; oral

1.5

10.9

410

2929

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

10.9

432

3118

B01AF02

ATC

apixaban; oral

1.4

10.9

477

3510

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.6

10.8

226

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.8

823

6640

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.3

10.8

S23.4

ICD-10 Finland

Sprain and strain of ribs and sternum

3.1

10.7

144

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.4

10.7

311

L74

ICPC

Fracture: hand/foot bone

2.3

10.7

374

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.4

10.7

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.7

10.7

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.7

10.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

10.7

501

3732

TGC00

NOMESCO Finland

Bronchial lavation

2.5

10.6

264

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

10.6

124

654

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.3

10.6

N05CD07

ATC

temazepam; oral

1.5

10.6

395

2819

N06AB04

ATC

citalopram; systemic

1.4

10.6

585

4483

S79.9

ICD-10 Finland

Unspecified injury of hip and thigh

3.3

10.5

120

N28

ICPC

Limited function/disability (N)

2.5

10.5

247

M03BX01

ATC

baclofen; systemic

2.8

10.5

184

N04BD01

ATC

selegiline; oral

2.7

10.5

201

K03.66

ICD-10 Finland

Tooth plaque

1.7

10.5

199

1216

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.6

10.4

242

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

10.4

755

6036

R1100, ,

SPAT

2.7

10.4

196

A01AB04

ATC

amphotericin B; local oral

1.7

10.4

185

1110

R95

ICPC

Chron obstructive pulmonary disease

2.3

10.4

341

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

10.4

316

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

10.3

583

4478

R42

ICD-10 Finland

Dizziness and giddiness

1.3

10.3

786

6328

ECB20

NOMESCO Finland

Oral alveoplasty

3.5

10.3

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

3.5

10.3

D07AC01

ATC

betamethasone; topical

1.3

10.3

902

7413

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.3

159

916

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

10.3

447

L04AA01

ATC

[U] ciclosporin

3.0

10.2

143

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

10.2

138

763

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

10.2

275

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

3.1

10.2

133

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

10.2

280

1873

J01DA01

ATC

[U] cefalexin

1.3

10.2

1526

13497

R03DA04

ATC

theophylline; systemic, rectal

1.8

10.2

150

853

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.6

10.1

228

R35

ICD-10 Finland

Polyuria

1.8

10.1

159

921

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

10.1

142

795

M05BA08

ATC

zoledronic acid; parenteral

7.9

10.1

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

10.1

183

1104

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

10.1

164

960

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

10.0

195

1198

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.8

10.0

R52.0

ICD-10 Finland

Acute pain

2.1

10.0

418

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

10.0

632

4941

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

10.0

243

1579

D01

ICPC

Abdominal pain/cramps general

1.5

10.0

321

2220

WX002

NOMESCO Finland

Sedation and analgesia

1.4

10.0

556

4259

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.6

9.9

207

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.2

9.9

400

A98

ICPC

Health maint/preventive medicine

1.6

9.9

2439

23282

R06AE07

ATC

cetirizine; oral

1.3

9.9

1126

9583

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.6

9.9

219

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.8

9.9

143

808

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.9

9.9

118

627

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.4

9.9

100

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

16.8

9.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

9.9

487

3655

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

9.9

461

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

9.8

185

1127

WZC30

NOMESCO Finland

Teaching

1.4

9.8

399

2890

NH3BG

NOMESCO Finland

MRI of foot

5.2

9.8

L09

ICPC

Arm symptom/complaint

1.8

9.8

136

759

S81.7

ICD-10 Finland

Multiple open wounds of lower leg

4.9

9.8

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

2.8

9.8

180

183

Kela drug reimbursment

Lamotrigin and topiramate

4.5

9.8

N03AF02

ATC

oxcarbazepine; oral

2.3

9.8

331

N03AG01

ATC

valproic acid; systemic, rectal

1.8

9.8

134

745

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.3

9.8

312

C03DA01

ATC

spironolactone; oral

1.4

9.8

400

2903

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.2

9.7

383

R4180

NOMESCO Finland

Podiatric therapy

3.0

9.7

142

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

9.7

638

5017

193

Kela drug reimbursment

Rasagiline

4.1

9.7

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.0

9.6

106

548

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

9.6

488

3679

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

9.6

824

6738

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

9.6

432

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

3.2

9.6

112

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

9.6

321

2239

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

9.6

237

1547

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

9.6

1151

9854

S06

ICPC

Rash localized

1.7

9.5

175

1059

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.8

9.5

138

780

OAB36

NOMESCO Finland

Guidance and counselling related to exercise

4.8

9.5

R13

ICD-10 Finland

Dysphagia

1.6

9.5

209

1325

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.6

9.5

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

9.5

354

U02

ICPC

Urinary frequency/urgency

1.4

9.5

532

4075

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.1

9.5

128

R1210, ,

SPAT

3.8

9.5

NCU20

NOMESCO Finland

Removal of internal fixation device from elbow or forearm

3.5

9.5

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

9.5

138

782

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.5

9.5

230

TNX30

NOMESCO Finland

Soft bandage, unspecified region

2.9

9.4

150

N03AE01

ATC

clonazepam; systemic

1.7

9.4

160

948

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

9.4

123

674

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

9.4

166

995

NDJ40

NOMESCO Finland

Closed reduction of fracture of wrist or hand

3.0

9.3

140

D10

ICPC

Vomiting

2.0

9.3

498

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

9.3

352

2513

M41.5

ICD-10 Finland

Other secondary scoliosis

4.4

9.3

J01FA06

ATC

roxithromycin; oral

1.3

9.3

1025

8663

H3603, E103,

ICD-10 Finland

6.9

9.3

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.9

9.3

146

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

9.3

173

1052

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.7

9.3

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

9.3

110

584

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.2

799

6535

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

3.1

9.2

120

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.5

9.2

221

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.7

9.2

186

NAJ22

NOMESCO Finland

Posterior reduction of fractrue of thoracic spine

13.7

9.2

K62.3

ICD-10 Finland

Rectal prolapse

2.3

9.1

296

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

9.1

482

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

3.6

9.1

R41.0

ICD-10 Finland

Disorientation, unspecified

1.9

9.1

116

631

S82.2

ICD-10 Finland

Fracture of shaft of tibia

2.9

9.1

148

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.4

9.1

247

NEJ50

NOMESCO Finland

Operation of fracture of pelvic ring

11.5

9.1

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

9.1

104

546

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.5

9.0

223

EBA10

NOMESCO Finland

Operative extraction of tooth

1.7

9.0

175

1075

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

9.0

436

R81

ICPC

Pneumonia

2.0

9.0

505

7330A

ICD-9 Finland

Other disorders of bone and cartilage, Osteoporosis[OSTEOPOROSIS CENTRALIS]

18.7

8.9

G04BD12

ATC

mirabegron; oral

1.4

8.9

413

3061

R07.3

ICD-10 Finland

Other chest pain

1.5

8.9

299

2085

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.2

8.9

112

R4190

NOMESCO Finland

Nutritional therapy

2.1

8.9

364

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

8.9

619

4902

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

8.9

425

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

8.9

378

K08.3

ICD-10 Finland

Retained dental root

1.6

8.9

191

1206

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

8.9

405

WX872

NOMESCO Finland

Intensive care

1.9

8.8

109

586

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

8.8

520

4012

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

8.8

333

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

8.8

114

624

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.7

8.7

168

S42.3

ICD-10 Finland

Fracture of shaft of humerus

2.5

8.7

203

L04AD01

ATC

ciclosporin; systemic

2.9

8.7

135

M01AH01

ATC

celecoxib; oral

1.4

8.7

553

4317

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

8.7

549

4281

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

8.7

1168

10102

J01MA14

ATC

moxifloxacin; systemic

1.6

8.7

204

1316

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

4.3

8.7

R52.1

ICD-10 Finland

Chronic intractable pain

3.5

8.6

L99

ICPC

Musculoskeletal disease other

2.1

8.6

409

J01AA02

ATC

doxycycline; systemic

1.3

8.6

1999

18520

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

8.6

310

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.4

8.6

253

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

8.6

499

M01AX17

ATC

nimesulide; oral

1.3

8.6

721

5859

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.6

959

8096

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

8.6

184

1161

P20

ICPC

Memory disturbance

1.3

8.5

577

4546

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

9.0

8.5

R03BA02

ATC

budesonide; inhalant

1.4

8.5

450

3410

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

2.3

8.5

280

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

8.5

200

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

8.4

237

1592

J02AC01

ATC

fluconazole; systemic

1.3

8.4

1047

8955

T92.1

ICD-10 Finland

Sequelae of fracture of arm

3.9

8.4

WW502

NOMESCO Finland

Autotransfusion

4.3

8.4

127

Kela drug reimbursment

Transplant complication

3.6

8.4

S51.0

ICD-10 Finland

Open wound of elbow

2.9

8.4

127

E000006, ,

ATC

1.6

8.4

210

1375

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.1

8.4

106

9522

FHL

Synovectomy

4.7

8.3

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

3.8

8.3

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.8

8.3

133

775

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.0

8.3

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

8.3

477

E000001, ,

ATC

1.4

8.3

463

3537

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

8.3

917

7725

T91.1

ICD-10 Finland

Sequelae of fracture of spine

9.5

8.3

A02BC04

ATC

rabeprazole; oral

1.6

8.3

220

1461

S20

ICPC

Corn/callosity

2.2

8.2

290

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.4

8.2

221

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

8.2

507

E83.51

ICD-10 Finland

Hypocalcemia

3.8

8.2

A07EA06

ATC

budesonide; oral, local oral

2.0

8.2

465

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.5

8.2

203

XKC03

NOMESCO Finland

Water cystometry

1.9

8.2

107

586

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

8.2

122

696

NDJ70

NOMESCO Finland

External fixation of fracture of wrist or hand

3.2

8.2

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

8.2

356

4758

Z3231

NOMESCO Finland

Registered nurse

1.3

8.2

668

5402

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

8.2

256

1760

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

8.2

512

3984

L08

ICPC

Shoulder symptom/complaint

1.3

8.2

605

4827

L84

ICD-10 Finland

Corns and callosities

1.9

8.1

101

545

AA1ED

NOMESCO Finland

Trauma CT of head and neck

3.6

8.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

8.1

123

706

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

8.1

358

SPAT1097

SPAT

Recording of ECG

1.4

8.1

432

3277

A06AH03

ATC

naloxegol; oral

2.7

8.1

152

E000003, ,

ATC

1.9

8.1

100

539

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.1

NDU10

NOMESCO Finland

Removal of external fixation device from wrist or hand

3.3

8.1

S32.4

ICD-10 Finland

Fracture of acetabulum

3.8

8.1

I50.0

ICD-10 Finland

Congestive heart failure

1.5

8.1

270

1882

D12

ICPC

Constipation

1.8

8.1

124

715

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

8.0

359

M01AB05

ATC

diclofenac; systemic, rectal

1.3

8.0

1547

13919

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

8.0

205

1348

A10BA02

ATC

metformin; oral

0.7

8.0

478

6079

M89.0

ICD-10 Finland

Algoneurodystrophy

3.6

8.0

M70.2

ICD-10 Finland

Olecranon bursitis

2.4

8.0

212

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.8

8.0

127

740

H04AA01

ATC

glucagon; nasal, parenteral

3.2

8.0

SPAT1252

SPAT

Overall medication plan or its review

1.5

7.9

218

1457

WGA11

NOMESCO Finland

Planning of pain management

4.3

7.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

7.9

234

1589

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

7.9

166

1042

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

7.9

465

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

7.9

107

594

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

6.6

7.9

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.8

346

2541

NH1AD

NOMESCO Finland

Ankle and foot CT

2.3

7.8

258

U07

ICPC

Urine symptom/complaint other

1.5

7.8

271

1902

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

7.8

488

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

7.8

120

692

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

7.8

284

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

1.8

7.8

108

604

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.9

7.8

100

546

B82

ICPC

Anaemia other/unspecified

1.9

7.7

490

R51.80

ICD-10 Finland

Headache

1.4

7.7

360

2669

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

7.7

574

4578

NAK30

NOMESCO Finland

Osteotomy of spine

15.1

7.7

NA2BG, ,

SPAT

6.4

7.7

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.8

7.7

128

M02AA07

ATC

piroxicam; topical

1.3

7.7

1098

9521

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.4

7.7

R30.0

ICD-10 Finland

Dysuria

1.8

7.7

107

600

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

7.6

186

1210

QDB10, ,

SPAT

2.0

7.6

394

L04AB04

ATC

adalimumab; parenteral

2.6

7.6

157

F05.9

ICD-10 Finland

Delirium, unspecified

2.1

7.6

360

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.0

7.6

415

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.0

7.6

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

7.6

318

2313

Z3226

NOMESCO Finland

Physiotherapist

1.4

7.6

468

3630

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

8.0

7.6

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

7.6

202

1342

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

3.6

7.6

R96

ICPC

Asthma

1.4

7.6

293

2101

D21

ICPC

Swallowing problem

2.4

7.5

218

N06AB10

ATC

escitalopram; oral

1.4

7.5

411

3127

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

7.5

204

1360

S82.5

ICD-10 Finland

Fracture of medial malleolus

2.6

7.5

158

J45.8

ICD-10 Finland

Mixed asthma

1.9

7.5

459

R10.0

ICD-10 Finland

Acute abdomen

2.0

7.5

410

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.4

7.5

206

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

1.6

7.5

162

1024

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

7.5

538

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

7.5

960

8209

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

7.1

7.5

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.4

245

1702

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.6

7.4

165

A10AA01, ,

ATC

2.5

7.4

171

A55

ICPC

General and Unspecified, Local injection/infiltration

3.6

7.4

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.3

7.4

A03

ICPC

Fever

1.4

7.4

292

2102

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

7.4

104

585

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

7.4

252

NC1AD

NOMESCO Finland

Elbow CT

3.8

7.4

R52.2

ICD-10 Finland

Other chronic pain

1.8

7.3

105

593

H53.2

ICD-10 Finland

Diplopia

1.9

7.3

477

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

7.3

414

S30.1

ICD-10 Finland

Contusion of abdominal wall

2.8

7.3

132

N17

ICPC

Vertigo/dizziness

1.4

7.3

441

3410

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.5

7.3

167

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

7.3

291

2100

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

7.2

567

4551

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.0

7.2

105

RD210, ,

NOMESCO Finland

2.8

7.2

127

R31

ICD-10 Finland

Unspecified haematuria

1.6

7.2

175

1138

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.2

691

5698

S81.0

ICD-10 Finland

Open wound of knee

2.4

7.2

192

K99

ICPC

Cardiovascular disease other

1.9

7.2

424

J01CA04

ATC

amoxicillin; systemic

1.3

7.2

1928

17921

P76

ICPC

Depressive disorder

1.8

7.2

113

657

NBU20

NOMESCO Finland

Removal of internal fixation device from shoulder or upper arm

3.6

7.1

H25.8

ICD-10 Finland

Other senile cataract

1.3

7.1

440

3413

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

7.1

289

ZY010

NOMESCO Finland

Hospital outpatient

1.9

7.1

433

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.8

7.1

110

637

C07AA05

ATC

propranolol; systemic

1.3

7.1

455

3549

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.4

7.1

206

T08

ICPC

Weight loss

2.1

7.1

283

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

7.1

666

5477

EC1VA, ,

NOMESCO Finland

1.8

7.0

105

601

M41.8

ICD-10 Finland

Other forms of scoliosis

3.0

7.0

S21

ICPC

Skin texture symptom/complaint

1.4

7.0

408

3133

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

7.0

270

1933

X57

ICD-10 Finland

Unspecified privation

2.2

7.0

264

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.2

7.0

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.5

7.0

170

D11

ICPC

Diarrhoea

1.4

7.0

266

1900

S29

ICPC

Skin symptom/complaint other

1.3

7.0

559

4496

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.2

7.0

K30

ICD-10 Finland

Functional dyspepsia

1.4

7.0

297

2166

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

7.0

169

1099

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

7.0

119

708

WW200

NOMESCO Finland

Immunization

2.2

7.0

252

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.4

6.9

189

SPAT1125

SPAT

Stoma care and guidance

2.0

6.9

339

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

6.9

163

1053

R03AC13

ATC

formoterol; inhalant

1.6

6.9

138

856

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

5.5

6.9

T93.1

ICD-10 Finland

Sequelae of fracture of femur

5.8

6.9

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.8

544

4371

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

6.8

209

XQ858, ,

SPAT

3.2

6.8

L04

ICPC

Chest symptom/complaint

1.6

6.8

173

1137

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

6.8

179

1186

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

6.8

314

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

4.1

6.8

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

6.8

117

698

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.4

6.8

185

WX882

NOMESCO Finland

High dependency care

2.1

6.8

308

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.8

363

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

6.7

384

T92.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of upper limb

4.3

6.7

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

2.7

6.7

132

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.1

6.7

269

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

6.7

486

3856

ZX114, ,

SPAT

2.5

6.7

168

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

22.6

6.7

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

6.7

390

4990

J01DA09

ATC

[U] cefadroxil

1.3

6.6

573

4653

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

1.8

6.6

479

J01XC01

ATC

fusidic acid; systemic

2.8

6.6

116

JN4BD

NOMESCO Finland

Extensive body CT

1.4

6.6

263

1894

J86.9

ICD-10 Finland

Pyothorax without fistula

4.0

6.6

RF220, ,

NOMESCO Finland

2.4

6.6

181

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.0

6.6

366

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.1

6.6

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

4.2

6.5

N04BC04

ATC

ropinirole; oral

2.6

6.5

140

U01

ICPC

Dysuria/painful urination

1.4

6.5

271

1969

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

6.5

129

800

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.4

6.5

189

XQ802

NOMESCO Finland

Epicutan test

1.8

6.5

483

-69

ICPC

Other reason for encounter NEC

1.7

6.5

106

624

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

6.5

104

1711

M05XX, ,

ATC

6.2

6.5

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

6.5

1539

14016

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

6.4

335

2527

105

Kela drug reimbursment

Adrenal cortical hypofunction

5.7

6.4

R4110

NOMESCO Finland

Physiotherapy

1.3

6.4

712

5961

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.8

6.4

565

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.4

6.4

165

Q78.00

ICD-10 Finland

Congenital osteogenesis imperfecta

70.0

6.4

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

6.4

228

ND1AD

NOMESCO Finland

Wrist CT examination

2.8

6.4

107

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

2.8

6.4

107

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.7

6.4

124

E86

ICD-10 Finland

Volume depletion

1.8

6.4

463

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

14.3

6.4

E883A

ICD-9 Finland

Fall into hole or other opening in surface

1.7

6.4

118

718

L81

ICPC

Injury musculoskeletal NOS

2.1

6.4

288

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

6.4

391

3026

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.3

6.4

197

S12.1

ICD-10 Finland

Fracture of second cervical vertebra

3.7

6.4

L04AA24

ATC

abatacept; parenteral

3.7

6.4

XQ848

NOMESCO Finland

Dermatological photography

1.9

6.3

407

S23.3

ICD-10 Finland

Sprain and strain of thoracic spine

6.6

6.3

S32.2

ICD-10 Finland

Fracture of coccyx

3.6

6.3

F10.24

ICD-10 Finland

Alcohol depence active use

3.6

6.3

UJD02

NOMESCO Finland

Gastroscopy

1.6

6.3

130

814

S19

ICPC

Skin injury other

1.7

6.3

100

584

OAB42

NOMESCO Finland

Guidance related to known health problem

11.0

6.3

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

6.3

253

1827

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

3.5

6.3

T08

ICD-10 Finland

Fracture of spine, level unspecified

9.3

6.3

R1250

NOMESCO Finland

Evaluation of functional capability

2.0

6.3

352

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

6.3

452

M05BB04

ATC

risedronic acid, calcium and colecalciferol, sequential; oral

3.8

6.3

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

3.8

6.3

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.3

489

3917

NG1DA

NOMESCO Finland

X-ray of knees

2.1

6.2

277

S99.9

ICD-10 Finland

Unspecified injury of ankle and foot

2.3

6.2

205

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.2

122

754

S51.8

ICD-10 Finland

Open wound of other parts of forearm

3.0

6.2

3006

Kela drug reimbursment

Baricitinib

7.0

6.2

R1430, ,

SPAT

2.3

6.2

193

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.7

6.2

109

655

R09

ICPC

Sinus symptom/complaint

1.5

6.2

172

1155

UJF92

NOMESCO Finland

Capsular endoscopy

2.2

6.2

219

RS121, ,

NOMESCO Finland

4.0

6.2

T84.2

ICD-10 Finland

Mechanical complication of internal fixation device of other bones

6.3

6.2

R15

ICD-10 Finland

Faecal incontinence

1.6

6.1

124

773

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.7

6.1

110

N05BA02

ATC

chlordiazepoxide; systemic

2.2

6.1

233

SXC03

NOMESCO Finland

Other oral or dental procedure

2.8

6.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

6.1

194

1340

V18.0

ICD-10 Finland

Pedal cyclist injured in noncollision transport accident, driver injured in nontraffic accident

3.8

6.1

J01FA09

ATC

clarithromycin; systemic

1.3

6.1

682

5714

NA3BG, ,

SPAT

1.9

6.1

356

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.0

6.1

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

6.1

116

713

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.0

6.1

301

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

6.1

479

3842

ZXE00

NOMESCO Finland

One hour or less

1.2

6.0

896

7744

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

3.1

6.0

S16

ICPC

Bruise/contusion

1.7

6.0

101

599

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

2.6

6.0

134

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

6.0

350

NDH10

NOMESCO Finland

Reduction of dislocation of joint of wrist, closed

6.7

6.0

NB3AA

NOMESCO Finland

Clavicle X-ray examination

2.5

6.0

140

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.0

279

2065

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.2

6.0

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.0

757

6426

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

231

36.07

307.65

1.8

1.5

0.32

0.45

ug/l

2.05

159

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2209

12899

5.36

254.41

4.7

2.5

86.82

82.07

nmol/l

13.65

2043

11285

(3003458) Phosphate [Moles/volume] in Serum or Plasma

937

3480

3.62

202.35

4.3

4.2

1.01

1.05

mmol/l

4.21

836

3146

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

797

2680

3.83

199.70

3.1

3.0

72.75

87.38

ng/l

6.58

648

2182

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2285

14918

4.95

196.14

12.2

6.4

1.23

1.22

mmol/l

1.15

1993

12717

(3020630) Protein [Mass/volume] in Serum or Plasma

765

2530

3.85

196.03

2.4

2.6

66.22

65.98

g/l

0.33

653

2258

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2081

13398

3.61

166.33

10.0

5.8

1.22

mmol/l

1.04

1951

12179

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

100

39.94

163.89

2.0

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1119

5336

2.90

149.47

1.5

1.3

1.12

1.34

u/ml

0.43

336

1275

(3036481) Cortisol [Moles/volume] in Serum or Plasma

666

2372

3.42

147.92

2.3

2.2

329.82

393.02

nmol/l

7.70

618

2148

(3018418) pH of Serum or Plasma

1596

9278

2.82

143.81

6.3

3.8

7.40

0.56

1338

6628

(3010838) Calcium [Moles/time] in 24 hour Urine

277

519

5.85

142.93

1.8

4.30

4.54

mmol/24h

0.54

211

434

(3034860) Kappa light chains.free [Mass/volume] in Serum

392

1051

4.21

131.33

2.6

3.1

56.09

97.89

mg/l

0.38

304

917

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

390

1050

4.18

129.86

2.6

3.1

28.57

46.33

mg/l

3.29

303

910

(3024561) Albumin [Mass/volume] in Serum or Plasma

1924

12988

2.77

118.25

6.8

4.4

33.93

34.85

g/l

10.26

1787

11993

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

349

933

4.16

116.82

2.6

2.9

2.70

4.90

ratio

0.84

209

557

(3015377) Calcium [Moles/volume] in Serum or Plasma

1629

10660

2.38

98.33

4.0

3.4

2.36

2.37

mmol/l

2.92

1453

9468

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1260

7622

2.25

88.49

3.1

2.5

3.07

3.04

mg/l

0.10

1091

6507

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

936

5092

2.30

83.98

2.4

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

842

4387

2.35

83.54

1.8

1.5

2.65

2.48

g/l

0.92

480

2316

(3022948) Iron [Moles/volume] in Serum or Plasma

892

4804

2.29

81.51

2.9

2.4

10.37

11.43

umol/l

4.71

808

4381

(3004789) Transferrin [Mass/volume] in Serum or Plasma

848

4477

2.32

81.18

2.8

2.4

2.33

g/l

0.00

765

4062

(3032080) INR in Blood by Coagulation assay

1806

12902

2.27

80.80

23.0

17.5

1.31

inr

0.00

1578

10713

(3026008) Bacteria identified in Urine by Culture

1639

11467

2.13

74.38

5.5

4.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

786

4147

2.27

74.25

2.9

2.4

18.75

19.71

1.23

702

3783

(3023368) Bacteria identified in Blood by Culture

1230

7757

2.10

73.40

5.3

4.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

356

1288

3.04

73.28

2.1

2.3

3.50

3.70

g/l

1.61

295

1154

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

356

1289

3.04

73.18

2.1

2.3

4.28

4.30

g/l

0.10

296

1153

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

356

1293

3.03

72.76

2.1

2.3

7.57

7.72

g/l

0.84

296

1157

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2358

19334

3.06

72.50

12.5

8.0

81.45

81.83

u/l

0.10

2274

18049

(3044927) Protein electrophoresis panel - Urine

153

313

5.13

70.86

1.2

—

(3022096) Basophils/Leukocytes in Blood

1606

11274

2.08

70.59

8.9

6.1

0.66

0.69

0.92

1500

10379

(3001604) Monocytes [#/volume] in Blood

1704

12231

2.11

70.48

8.3

5.8

0.60

0.59

e9/l

0.71

1499

10173

(3006504) Eosinophils/Leukocytes in Blood

1604

11271

2.08

70.10

8.7

6.0

2.60

2.75

1.76

1493

10389

(3013115) Eosinophils [#/volume] in Blood

1743

12635

2.12

69.97

8.6

5.9

0.17

0.18

e9/l

1.99

1536

10680

(3019069) Monocytes/Leukocytes in Blood

1607

11309

2.08

69.83

8.9

6.1

9.03

8.94

0.61

1499

10408

(3006315) Basophils [#/volume] in Blood

1707

12291

2.10

69.59

8.4

5.8

0.04

e9/l

0.43

1503

10228

(3021960) Folate [Moles/volume] in Serum or Plasma

1354

8994

2.04

68.56

2.1

1.8

21.75

21.44

nmol/l

0.26

1141

7396

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

332

1208

3.00

67.41

2.0

2.3

2.90

2.98

g/l

0.80

272

1071

(3018010) Neutrophils/Leukocytes in Blood

1584

11196

2.04

66.63

8.5

6.0

60.12

58.12

8.30

1503

10546

(3019198) Lymphocytes [#/volume] in Blood

1718

12513

2.07

66.36

8.5

5.8

1.65

1.85

e9/l

8.00

1526

10653

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2251

18263

2.58

66.20

7.6

4.8

17.79

15.49

mm/h

7.81

2105

16750

(3012095) Magnesium [Moles/volume] in Serum or Plasma

823

4606

2.14

65.75

3.4

2.7

0.80

0.81

mmol/l

2.35

749

4225

(3037756) Immunofixation for Serum or Plasma

222

652

3.63

63.87

1.4

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

309

1120

2.99

63.01

2.1

2.3

1.16

0.86

g/l

0.31

224

949

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

722

3896

2.17

62.90

2.3

1.8

—

(3002030) Lymphocytes/Leukocytes in Blood

1597

11457

2.00

62.72

8.8

6.1

24.41

26.83

15.45

1510

10687

(3013650) Neutrophils [#/volume] in Blood by Automated count

1850

14096

2.04

59.74

11.5

9.1

4.37

4.14

e9/l

3.24

1639

12043

(3027945) Reticulocytes/Erythrocytes in Blood

641

3373

2.19

59.00

2.5

2.4

1.93

1.88

0.39

564

2944

(36660697) Celiac disease serology panel - Serum

429

1908

2.49

58.38

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2177

17715

2.31

58.13

9.1

6.2

3201.20

5083.09

e6/l

0.64

245

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

301

1124

2.89

57.98

2.1

2.2

9.82

10.06

g/l

0.40

237

973

(3023520) Reticulocytes [#/volume] in Blood

537

2658

2.28

57.24

2.5

2.4

70.29

70.08

e9/l

0.04

414

1902

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1262

8527

1.92

57.21

3.5

2.5

58.00

60.48

u/l

0.49

1156

7731

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

536

2658

2.28

56.85

2.2

2.0

0.19

0.20

g/l

2.35

475

2459

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1831

14043

1.99

56.10

7.5

6.0

10.95

11.21

umol/l

0.25

1740

13230

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1511

10918

1.90

54.83

4.1

3.0

118.27

116.54

ug/l

0.08

1364

9842

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

662

3620

2.11

54.63

2.3

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1576

11575

1.90

54.01

3.6

2.7

—

estimate

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1945

15332

2.02

53.77

6.9

4.6

6.63

6.75

mmol/l

2.38

1901

14521

(3003181) Sodium [Moles/volume] in Urine

225

745

3.21

53.36

1.6

1.4

57.27

58.62

mmol/l

0.21

179

604

(3019309) Folate [Moles/volume] in Red Blood Cells

943

5901

1.93

52.82

2.0

1.8

1245.60

1190.56

nmol/l

0.99

684

4304

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1294

8970

1.87

52.72

2.6

2.2

158.77

172.48

u/l

0.63

1222

8377

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

246

882

2.97

50.80

1.9

2.2

0.01

0.00

g/l

0.50

184

775

(3047181) Lactate [Moles/volume] in Blood

222

779

3.02

47.56

6.7

5.1

1.21

1.26

mmol/l

0.33

202

701

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

568

3098

2.06

46.26

4.0

249.70

251.14

u/l

0.08

532

2890

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1455

10743

1.79

45.61

5.9

4.4

291.38

64.08

ng/l

0.42

1207

8370

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

241

920

2.78

44.18

1.9

2.2

0.00

0.05

g/l

1.39

191

823

(3005719) IgG [Mass/volume] in Serum or Plasma

359

1659

2.35

44.12

3.6

3.0

10.27

10.54

g/l

0.29

328

1506

(3026782) Osmolality of Urine

848

5373

1.85

43.98

4.0

3.0

456.04

483.50

mosm/kgh2o

4.15

750

4673

(3002179) Metamyelocytes/Leukocytes in Blood

430

2153

2.19

43.56

4.2

3.9

0.65

0.67

0.08

156

606

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1359

9984

1.74

41.96

3.8

3.3

1494.60

1596.37

ng/l

0.51

1196

8665

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1711

13430

1.78

41.69

4.5

3.2

59.33

50.12

u/l

2.06

1569

12091

(3003396) Base excess in Arterial blood by calculation

572

3245

1.97

41.18

7.1

5.7

1.95

1.25

mmol/l

3.17

486

2689

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

163

520

3.28

40.95

1.2

1.1

42.62

11.28

eliau/ml

—

(3017181) Myelocytes/Leukocytes in Blood

440

2274

2.12

40.92

4.4

4.0

0.91

0.92

0.01

156

654

(3025159) Blasts/Leukocytes in Blood

426

2179

2.14

40.68

4.7

4.3

0.90

0.41

0.30

134

521

(3007853) Bacteria identified in Skin by Aerobe culture

526

2910

2.01

40.63

2.3

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

472

2516

2.07

40.38

6.0

3.5

1.24

mmol/l

0.04

438

2113

(3035350) Ketones [Presence] in Urine by Test strip

1736

13801

1.75

39.18

7.0

5.1

2.89

3.24

estimate

0.04

431

3049

(3002173) Hemoglobin [Mass/volume] in Arterial blood

494

2709

2.01

38.96

7.6

6.2

113.76

117.02

g/l

3.51

478

2649

(3019977) pH of Arterial blood

569

3279

1.94

38.86

7.4

5.8

7.43

7.42

1.05

358

1788

(3018572) Chloride [Moles/volume] in Blood

166

555

3.12

38.55

7.1

5.7

103.95

104.63

mmol/l

0.86

152

500

(3039000) Anion gap in Blood by calculation

166

555

3.12

38.55

7.1

5.7

10.72

10.90

mmol/l

0.28

152

499

(3009261) Glucose [Presence] in Urine by Test strip

1743

13922

1.74

38.14

7.0

5.1

0.05

0.01

estimate

0.36

422

2904

(3008152) Bicarbonate [Moles/volume] in Arterial blood

364

1796

2.19

37.93

7.1

5.9

25.36

24.84

mmol/l

1.84

347

1721

(3007930) Methemoglobin/Hemoglobin.total in Blood

279

1233

2.41

37.68

6.1

4.2

0.90

0.88

0.30

266

1175

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

984

6750

1.73

37.62

3.5

3.0

2.49

2.48

mmol/l

1.20

905

6037

(3021440) Promyelocytes/Leukocytes in Blood

418

2183

2.09

37.58

4.5

4.1

0.10

0.02

132

565

(3016502) Oxygen saturation in Arterial blood

511

2873

1.97

37.38

7.2

5.9

95.59

95.53

0.09

488

2776

(3021601) Nitrite [Presence] in Urine by Test strip

1711

13634

1.72

37.35

7.0

5.0

0.00

estimate

-0.00

415

2854

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

563

3274

1.91

37.24

7.4

5.8

5.19

5.12

kpa

0.81

539

3138

(3037121) Protein [Mass/volume] in Urine

226

911

2.62

37.09

2.3

2.7

235.95

389.53

mg/l

0.98

300

(3027801) Oxygen [Partial pressure] in Arterial blood

562

3273

1.91

36.98

7.3

5.8

11.55

12.19

kpa

2.75

537

3130

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

292

1337

2.33

36.35

6.1

4.0

1.73

1.49

2.82

279

1275

(3028026) IgM [Mass/volume] in Serum or Plasma

292

1338

2.33

36.28

2.4

1.8

1.38

1.37

g/l

0.02

263

1186

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1650

13073

1.70

36.23

2.8

2.3

97.90

97.60

pmol/l

0.08

857

6104

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

317

1507

2.25

36.10

8.9

7.3

15.17

15.45

1.25

303

1459

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1423

10939

1.65

34.21

2.8

2.4

—

(3008295) Osmolality of Serum or Plasma

121

359

3.48

34.07

1.4

1.3

266.77

271.06

mosm/kgh2o

1.09

256

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

498

3.07

33.35

1.4

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

892

6113

1.69

33.25

3.6

2.8

6.90

7.25

e6/l

0.36

833

5541

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

434

2399

1.97

33.00

2.0

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

203

827

2.58

32.52

2.0

2.3

0.00

g/l

-0.00

184

772

(3016038) Potassium [Moles/volume] in Urine

235

4.02

32.19

1.2

1.1

29.63

32.67

mmol/l

0.69

199

(3002582) Erythrocytes [#/volume] in Urine

1184

8789

1.63

31.93

4.4

3.5

35.50

49.77

e6/l

0.89

968

6598

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

242

1080

2.37

31.82

2.1

1.8

1.25

2.30

ug/l

1.26

212

934

(40760892) CBC W Ordered Manual Differential panel - Blood

719

4695

1.73

31.73

6.5

4.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

954

6724

1.66

31.54

6.5

4.5

0.31

0.49

estimate

0.27

357

2246

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

317

1591

2.13

31.33

4.5

3.5

5.29

5.23

kpa

0.46

296

1503

(3009343) pH of Capillary blood

310

1544

2.14

31.25

4.4

3.5

7.42

0.72

252

1267

(3042936) Bacteria identified in Isolate by Culture

585

3620

1.79

31.05

2.7

1.9

—

(3019225) pH of Specimen

501

2960

1.85

30.94

7.9

4.4

7.36

7.37

0.45

371

1994

(3017704) Immunofixation for Urine

145

4.86

30.92

1.4

1.6

—

(3015736) pH of Urine

1414

11063

1.60

29.95

5.6

4.4

6.50

6.36

4.02

766

5713

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

161

4.57

29.95

1.2

1.1

106.55

67.88

u/l

1.24

142

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

161

4.57

29.95

1.2

1.1

36.94

21.46

u/l

0.65

141

(3035637) Corticotropin [Mass/volume] in Plasma

276

3.61

29.11

1.3

1.5

26.57

22.50

ng/l

0.27

276

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2183

19144

1.81

28.70

6.2

5.2

15.67

15.24

pmol/l

11.07

1997

17194

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1296

10007

1.58

28.48

7.4

5.2

0.68

0.56

estimate

0.09

346

2252

(3044640) Blood type and Crossmatch panel - Blood

1129

8460

1.58

28.12

3.1

2.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

118

5.09

28.01

1.5

1.8

3.92

6.14

nmol/l

0.44

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

271

1335

2.15

27.99

4.4

3.4

2.69

2.31

mmol/l

0.76

215

1024

(3017732) Neutrophils [#/volume] in Blood

498

3031

1.79

27.60

3.8

3.2

4.43

4.54

e9/l

0.22

398

2490

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

271

1345

2.13

27.44

1.9

1.6

1.60

1.59

g/l

0.02

239

1154

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

285

1465

2.06

26.26

1.6

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

497

3098

1.74

25.14

1.5

1.3

581.58

566.35

titre

0.06

139

769

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

295

3.30

24.93

1.2

61.23

60.97

u/l

0.02

257

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

235

1148

2.15

24.72

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

873

6303

1.58

24.69

2.0

1.8

43564849.58

20770013.33

pmol/l

0.48

707

4964

(3023419) Bacteria identified in Sputum by Culture

320

3.18

24.34

2.9

2.5

—

(3018095) Leukocytes [#/volume] in Urine

1259

9888

1.52

24.10

5.4

4.3

114.35

136.28

e6/l

0.64

977

6806

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2449

22570

2.18

24.09

34.1

18.9

23.76

24.58

mg/l

0.77

2266

19051

(36304419) Bacteria [Presence] in Urine

972

7231

1.54

23.87

4.4

3.3

0.00

273.11

estimate

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

456

2814

1.75

23.78

5.7

3.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

148

603

2.54

23.65

1.5

1.3

—

(40768797) Stomach Pathology biopsy report

560

3662

1.67

23.58

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

435

2656

1.76

23.52

4.6

3.2

213.61

225.03

ng/l

0.22

407

2434

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

236

3.51

23.49

1.4

1.2

102.65

115.66

pmol/l

0.73

236

(3020779) Urea [Moles/volume] in Serum or Plasma

384

2263

1.82

23.40

6.9

5.2

9.86

10.45

mmol/l

0.78

367

2131

(1616796) Gas panel - Central venous blood

136

538

2.61

23.09

4.3

3.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2380

21768

1.95

23.03

8.0

6.6

2.04

2.03

mu/l

0.03

2203

19738

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

296

1616

1.94

22.88

3.2

3.0

4.18

4.36

pmol/l

2.72

241

1401

(3030467) Casts [#/volume] in Urine by Automated count

1015

7705

1.52

22.28

4.5

3.4

0.39

0.55

e6/l

2.07

806

5625

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

785

5644

1.56

22.10

5.8

4.3

197.37

205.68

ng/l

0.06

694

4832

(3021447) Carbon dioxide [Partial pressure] in Venous blood

467

2968

1.70

21.73

4.2

3.1

6.00

5.82

kpa

2.51

450

2905

(3009445) Proteinase 3 Ab [Units/volume] in Serum

207

1013

2.13

21.63

1.4

1.5

2.70

15.28

iu/ml

—

(3002032) Base excess in Venous blood by calculation

454

2874

1.70

21.41

4.2

3.1

2.88

2.06

mmol/l

4.39

402

2554

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

341

2.95

21.24

1.5

1.3

—

(3012501) Base excess in Blood by calculation

130

525

2.55

21.17

4.6

3.6

3.19

3.02

mmol/l

0.24

103

385

(3012544) pH of Venous blood

465

2971

1.69

21.16

4.4

3.1

7.38

0.34

276

1672

(3018677) aPTT in Platelet poor plasma by Coagulation assay

588

3999

1.61

20.86

2.3

1.9

29.48

29.44

0.05

571

3861

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

412

2.74

20.81

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

319

1838

1.84

20.80

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

184

875

2.19

20.67

3.0

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

866

6442

1.51

20.52

3.0

2.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

121

489

2.55

19.68

1.5

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

149

664

2.32

19.57

2.0

1.5

0.22

0.23

g/l

0.35

140

626

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

142

623

2.35

19.33

1.5

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

151

681

2.29

19.29

2.0

1.5

1.13

1.20

g/l

2.17

144

642

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

954

7316

1.48

19.13

4.7

3.0

33.12

33.25

u/l

0.02

887

6793

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

757

5572

1.50

18.47

2.0

1.7

1.43

1.42

mg/l

0.03

616

4348

(3000494) Fungus identified in Specimen by Culture

438

2855

1.64

18.22

1.7

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

193

986

2.03

17.96

2.5

2.0

599.77

764.03

ug/l

0.24

175

930

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

186

939

2.06

17.88

2.4

1.9

41.92

40.01

u/l

0.50

148

823

(3006184) Hemoglobin [Mass/volume] in Capillary blood

146

674

2.23

17.65

2.5

2.2

120.48

123.03

g/l

0.76

125

518

(3018133) Calcium [Moles/volume] in Urine

6.36

17.56

1.2

1.3

2.90

3.02

mmol/l

0.08

(3045716) Anion gap in Serum or Plasma by calculation

310

2.80

16.96

2.9

2.4

11.51

10.61

mmol/l

1.30

305

(3029937) Albumin [Presence] in Urine by Test strip

998

7856

1.43

16.87

7.7

5.2

0.00

estimate

0.50

398

2667

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

363

2.65

16.80

4.2

3.6

2680.91

375.33

iu/ml

0.97

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

104

427

2.49

16.40

1.5

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

318

2.73

16.17

9.0

5.9

13.53

13.44

mg/l

0.05

294

(3019150) Specific gravity of Urine by Refractometry

805

6129

1.45

16.12

7.4

5.5

2.71

1.02

kg/l

0.50

594

4089

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

322

2011

1.68

15.68

2.0

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

911

7133

1.42

15.53

4.6

3.8

0.00

0.05

3.01

307

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

137

650

2.17

15.49

2.7

2.4

1.63

1.65

mg/l

0.11

121

565

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

126

578

2.24

15.48

2.6

2.1

11.82

12.74

mg/l

0.56

105

535

(3011412) CD3 cells [#/volume] in Blood

145

3.57

15.43

2.6

1.5

1003.40

1020.38

e6/l

0.05

131

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

133

633

2.16

14.93

1.6

1.5

0.09

0.32

iu/ml

1.08

129

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

4.44

14.73

2.4

1.5

245.00

197.73

e6/l

0.45

(3000012) Reticulocyte production index

400

2.45

14.70

1.7

2.0

0.92

0.88

0.19

262

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

165

857

1.99

14.66

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

791

6108

1.42

14.32

2.9

2.6

321.47

336.71

umol/l

3.11

668

5122

(21494890) Protein electrophoresis panel - 24 hour Urine

276

2.73

14.20

1.7

1.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

136

667

2.10

14.14

2.3

1.5

25.35

16.59

iu/ml

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

300

1888

1.66

14.14

3.9

2.7

122.43

125.72

g/l

2.06

288

1838

(3027135) IgG subclass 1 [Mass/volume] in Serum

179

3.17

14.13

1.3

1.4

5.93

6.89

g/l

1.22

132

(3024139) IgG subclass 3 [Mass/volume] in Serum

179

3.17

14.13

1.3

1.4

0.29

0.41

g/l

1.89

133

(3028192) IgG subclass 2 [Mass/volume] in Serum

179

3.17

14.13

1.3

1.4

1.94

2.82

g/l

4.84

133

(3024354) Oxygen [Partial pressure] in Venous blood

381

2545

1.58

14.09

3.7

2.8

4.34

4.31

kpa

0.07

365

2482

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

146

3.40

13.84

1.5

1.2

0.62

1.44

u/ml

0.57

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

417

2860

1.54

13.70

3.0

2.3

9.07

8.42

umol/l

0.14

342

2443

(40761511) CBC panel - Blood by Automated count

2398

22562

1.69

13.34

31.6

17.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

4.24

13.16

2.3

1.4

504.76

402.65

e6/l

0.41

(3014111) Lactate [Moles/volume] in Serum or Plasma

373

2526

1.56

12.93

6.9

5.4

1.36

1.33

mmol/l

0.22

363

2476

(3019550) Sodium [Moles/volume] in Serum or Plasma

2472

23485

1.83

12.89

40.6

23.6

138.56

139.53

mmol/l

40.76

2444

22968

(4062490) Immunoglobulin typing, IgG

179

3.06

12.85

1.3

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

223

2.82

12.77

1.5

92.63

94.36

ng/l

0.05

223

(3000570) Elastase.pancreatic [Mass/mass] in Stool

166

906

1.89

12.76

1.4

246.26

275.70

ug/g

0.95

533

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

182

1023

1.84

12.75

2.3

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2473

23509

1.82

12.70

40.7

23.8

3.97

mmol/l

0.05

2443

22957

(3023183) Ammonium ion [Moles/volume] in Plasma

429

2.28

12.60

2.7

2.2

32.26

31.16

umol/l

0.18

370

(3024980) IgG subclass 4 [Mass/volume] in Serum

302

2.53

12.39

1.4

1.5

0.63

0.71

g/l

0.14

234

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.71

12.35

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

138

717

1.98

12.28

1.5

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

293

1898

1.61

12.26

1.4

—

(3000991) Gas panel - Venous blood

351

2374

1.55

12.20

8.0

6.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

128

3.40

12.19

2.2

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

174

3.03

12.19

1.4

1.5

6.99

7.20

u/l

0.04

140

(3022313) Gas panel - Capillary blood

187

1079

1.79

12.03

4.6

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

189

1095

1.78

11.99

2.5

1.9

—

(3052851) Hemolysis interference index of Serum or Plasma

147

787

1.92

11.99

3.5

1.42

2.17

index

0.97

390

(3017143) Hepatitis C virus Ab [Presence] in Serum

264

1679

1.64

11.89

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

209

1251

1.73

11.84

1.6

1.3

194.67

171.81

u/ml

0.18

187

1140

(3004809) Band form neutrophils/Leukocytes in Blood

418

2.24

11.64

3.0

3.6

1.51

1.70

0.17

363

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

254

1618

1.63

11.36

4.2

3.1

24.76

24.51

mmol/l

0.54

247

1597

(3015171) Extractable nuclear Ab [Units/volume] in Serum

166

941

1.82

11.33

1.4

1.2

4.99

1.27

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

116

584

2.03

11.29

1.8

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

369

2564

1.51

11.29

2.9

2.5

5.21

5.54

ug/l

0.17

285

2141

(3026389) Candida sp identified in Specimen by Organism specific culture

431

2.20

11.22

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

137

733

1.92

11.21

1.6

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

410

2916

1.48

11.18

2.3

1.9

215.89

151.92

ug/g

1.73

331

2226

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

136

727

1.92

11.15

2.2

1.8

3.56

12.50

iu/l

0.49

258

(3035933) Granulocytes/Leukocytes in Blood

101

485

2.13

11.15

3.7

3.2

59.64

58.26

0.41

101

485

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

395

2.24

11.04

1.4

1.3

13.84

24.90

u/ml

—

(3025549) Creatine [Moles/time] in 24 hour Urine

10.07

10.99

1.7

—

(40761536) Microorganisms panel - Urine sediment

300

2005

1.56

10.96

7.9

5.0

—

(3033658) Prothrombin time (PT) actual/Normal

800

6413

1.36

10.96

5.0

3.8

88.51

89.27

0.34

779

6259

(3009508) Creatinine [Moles/volume] in Urine

1062

8893

1.32

10.77

3.4

3.2

5.15

5.85

mmol/l

9.65

888

7285

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2478

23695

1.75

10.73

43.7

26.0

72.18

74.45

umol/l

2.97

2453

23303

(3030981) Hyaline casts [#/volume] in Urine by Automated count

316

2148

1.54

10.69

2.5

2.3

0.70

0.59

e6/l

0.26

298

2062

(3040151) Glucose [Moles/volume] in Capillary blood

303

2.38

10.41

4.5

6.84

7.34

mmol/l

0.78

251

(3008757) Leukocyte morphology finding [Identifier] in Blood

243

2.55

10.36

2.8

3.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2444

23311

1.65

10.33

18.9

13.4

21.02

22.36

u/l

5.00

2369

22369

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.29

10.30

1.2

2.0

5586.29

191710.86

u/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

222

1405

1.63

10.19

3.9

2.9

26.44

25.46

mmol/l

3.61

213

1376

(44790047) Parainfluenza type 1 nucleic acid detection

278

2.41

9.97

1.5

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

278

2.41

9.97

1.5

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

278

2.41

9.97

1.5

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

278

2.41

9.97

1.5

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

547

4180

1.39

9.97

1.4

1.3

25.02

14.03

u/ml

1.52

188

1439

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

581

4485

1.38

9.96

1.4

1.3

44.55

38.35

iu/ml

0.41

209

1410

(3020876) Protein [Mass/time] in 24 hour Urine

297

2.36

9.94

1.6

2.0

0.72

0.94

g/24h

0.42

152

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

285

1926

1.54

9.88

1.7

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

442

2.10

9.79

1.3

1.2

111.11

327.23

titre

—

(3023420) DNA double strand Ab [Units/volume] in Serum

166

983

1.73

9.79

2.3

1.6

8.96

6.11

iu/ml

0.55

231

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

294

2.35

9.71

1.9

1.7

227.00

608.38

u/ml

—

(3025941) Bacteria identified in Stool by Culture

201

1256

1.65

9.70

1.4

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.51

9.62

1.6

17.25

16.07

pmol/l

0.62

(3021589) Normoblasts [#/volume] in Blood

1224

10565

1.30

9.55

21.7

12.2

0.00

e9/l

0.52

1033

8503

(3010813) Leukocytes [#/volume] in Blood

2479

23791

1.69

9.46

50.1

29.3

7.00

6.74

e9/l

5.52

2436

23049

(3014271) Vancomycin [Susceptibility]

195

2.65

9.43

3.8

3.0

—

(3035941) MCH [Entitic mass]

2478

23787

1.68

9.34

49.9

29.1

30.33

30.21

2.38

2458

23410

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2478

23788

1.68

9.33

50.7

29.6

37.56

38.59

20.71

2458

23409

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2478

23788

1.68

9.33

49.9

29.2

92.30

91.67

8.82

2458

23410

(3007461) Platelets [#/volume] in Blood

2478

23788

1.68

9.33

50.1

29.3

263.47

254.77

e9/l

6.95

2438

23163

(3026361) Erythrocytes [#/volume] in Blood

2478

23788

1.68

9.33

50.1

29.2

4.14

4.29

e12/l

48.87

2436

23052

(3017569) Oxygen content in Arterial blood

146

2.91

9.28

2.1

1.8

15.35

15.64

0.31

146

(3000963) Hemoglobin [Mass/volume] in Blood

2478

23791

1.68

9.28

50.5

29.5

124.09

128.62

g/l

56.06

2458

23436

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

251

1673

1.55

9.26

2.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

3.56

9.22

1.8

1.4

2.12

2.06

umol/l

0.08

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.56

9.22

1.5

1.6

57.55

150.33

umol/l

1.25

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

153

2.84

9.12

1.3

1.1

—

(3011985) Renin [Units/volume] in Plasma

385

2.11

8.85

1.8

1.3

55.01

46.24

mu/l

0.15

339

(3014148) Varicella zoster virus Ab [Titer] in Serum

134

2.94

8.81

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

614

4868

1.34

8.72

3.7

3.1

1.52

1.58

e6/l

0.15

343

2536

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

152

909

1.71

8.67

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

208

1354

1.58

8.51

1.8

1.5

1.57

1.47

1.37

161

1133

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

100

3.23

8.49

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

100

3.23

8.49

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

100

3.23

8.49

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

100

3.23

8.49

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

256

2.33

8.40

3.1

3.3

60.81

57.65

0.51

211

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

441

2.01

8.39

1.5

1.4

—

(3022145) Colonoscopy Study observation

382

2822

1.41

8.38

1.3

—

(3042631) Mycobacterium sp identified in Specimen

347

2.14

8.35

2.3

3.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

176

1106

1.63

8.33

1.3

1.2

—

(40758558) Short blood count panel - Blood

919

7746

1.29

8.27

7.9

6.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2279

21587

1.41

8.20

7.3

39.66

40.15

mmol/mol

1.85

2029

19621

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

141

840

1.72

8.17

5.1

3.8

25.32

25.28

mmol/l

0.05

119

741

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

234

1589

1.52

7.93

8.1

6.8

25.28

24.55

mmol/l

1.76

228

1545

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

122

704

1.77

7.92

2.0

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

166

2.62

7.86

1.2

122.97

79.34

u/l

1.01

139

(3042111) Morphology [Interpretation] in Bone marrow Narrative

441

1.96

7.71

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

101

3.09

7.70

2.0

2.1

15.83

15.87

nmol/l

0.01

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

163

2.60

7.60

1.2

27.56

22.87

u/l

0.25

131

(3000475) Leukocytes [#/volume] in Synovial fluid

121

707

1.75

7.54

1.9

1.6

6533.67

13610.80

e6/l

2.78

490

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

3.40

7.52

2.4

2.1

317.36

304.89

mu/l

0.06

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

106

601

1.80

7.32

2.5

3.0

132.00

1103.63

u/ml

1.33

532

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

279

2.18

7.30

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

3.11

7.28

2.5

2.3

34.37

43.84

1.76

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2258

21450

1.36

7.15

31.6

19.4

72.07

70.53

ml/min/173m2

3.23

2148

20101

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

525

1.84

7.14

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

374

2829

1.38

7.09

2.8

2.3

0.00

0.02

estimate

1.26

515

(4024509) Urine culture

228

1577

1.49

7.08

2.4

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

122

733

1.70

6.90

1.7

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

369

1.98

6.80

1.2

1.3

—

nmol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

150

2.56

6.69

1.0

1.1

2.01

18.79

nmol/l

—

(3004451) EKG impression Narrative

169

2.45

6.60

1.4

1.3

—

(3044941) Cell count panel - Synovial fluid

502

1.82

6.59

1.7

1.4

—

(3013512) EKG study

1119

9844

1.24

6.54

4.9

4.1

0.80

0.74

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

333

2.01

6.53

1.7

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

183

2.37

6.47

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

183

2.37

6.47

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

183

2.37

6.47

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

159

2.47

6.43

1.1

—

(3045424) Erythrocytes [Presence] in Urine

199

1370

1.49

6.34

2.7

2.2

0.00

estimate

0.50

409

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

263

2.11

6.29

4.3

3.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

331

1.99

6.28

1.6

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

539

4373

1.29

6.26

3.9

3.1

3.74

4.56

e6/l

0.96

258

2022

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1902

17766

1.25

6.14

41.8

24.0

14.42

13.94

29.33

1891

17483

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.41

6.14

1.5

1.6

10.32

10.13

ug/l

0.05

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

226

2.19

6.14

1.6

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

127

2.62

6.13

1.5

1.3

27.75

24.82

u/l

0.35

(3003329) Lymphocytes/Leukocytes in Synovial fluid

220

2.20

6.10

2.1

1.6

26.24

32.10

0.67

135

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

560

1.74

6.08

3.1

2.2

3.36

3.57

g/l

0.78

540

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.10

6.04

3.7

2.3

5.10

4.93

kpa

0.26

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

158

2.43

6.03

1.7

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

357

1.93

6.03

1.2

233.25

283.96

pmol/l

1.05

303

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.06

5.92

3.7

2.3

9.18

10.00

kpa

0.54

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

138

892

1.58

5.89

2.9

2.8

0.36

0.38

iu/ml

0.18

526

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.39

5.85

1.5

1.7

40.57

45.64

umol/l

0.20

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.93

5.73

1.4

1.5

83.72

395.67

nmol/24h

0.48

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

150

2.42

5.71

1.7

1.3

—

(3003694) ABO and Rh group [Type] in Blood

674

5675

1.25

5.71

1.4

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

309

1.96

5.65

1.9

1.5

65.68

59.34

0.69

197

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.30

5.58

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

529

1.73

5.58

1.6

1.4

0.30

0.32

mg/l

0.12

175

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.02

5.56

1.4

1.3

73.99

1301.53

u/l

0.53

(3039162) Centromere protein B Ab [Units/volume] in Serum

304

1.96

5.55

1.5

1.2

40.60

54.79

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2300

22069

1.33

5.53

5.8

5.9

5.88

6.02

mmol/l

4.98

2013

19625

(21494814) CD8 cells/Lymphocytes in Specimen

3.00

5.53

2.7

1.6

28.74

31.05

0.28

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.00

5.53

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

5.86

5.52

3.6

3.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

166

2.31

5.44

1.5

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

474

1.75

5.40

1.3

1.2

3.70

3.86

mmol/l

0.65

451

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

253

2.04

5.34

1.2

1.1

240.60

309.44

u/ml

1.09

140

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

213

2.13

5.33

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

101

622

1.65

5.28

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

101

622

1.65

5.28

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

255

2.02

5.24

1.6

1.4

66510.27

188594.10

e6/l

0.94

162

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

594

1.66

5.19

1.5

1.2

3.02

3.53

u/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

417

3349

1.29

5.18

3.1

3.8

11.27

17.05

ug/l

0.50

349

2742

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

121

2.50

5.12

3.0

4.6

—

(3024928) Oxygen saturation in Venous blood

107

675

1.61

5.10

3.1

2.3

59.37

57.49

0.31

100

652

(3043410) Blood group antigens tested for on Red Blood Cells

3.29

5.02

1.7

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

2.25

5.01

1.7

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

200

1444

1.42

5.01

1.2

94.77

126.70

u/ml

0.89

512

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

463

1.73

4.98

1.3

1.2

46.77

31.29

e6/l

0.14

339

(3022493) Free Hemoglobin [Mass/volume] in Plasma

105

2.59

4.97

2.3

5.6

71.43

63.62

mg/l

0.23

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

296

1.91

4.93

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

136

2.37

4.90

1.8

1.7

38.64

39.14

g/l

0.18

136

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

304

1.89

4.89

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.35

4.88

1.4

1.3

1.80

1.85

mmol/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

466

1.72

4.88

1.4

1.3

2188.85

1029.61

e6/l

0.25

367

(3008536) Aspergillus sp Ab [Presence] in Serum

4.85

4.80

1.2

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

113

734

1.56

4.78

1.5

1.2

45.89

42.08

u/ml

—

(21494434) Karyotype in Bone marrow

211

2.06

4.68

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

3.03

4.67

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

288

1.89

4.65

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

444

1.71

4.59

1.3

0.52

0.30

nmol/l

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

186

2.11

4.58

1.2

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

122

2.39

4.56

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

269

1.91

4.55

4.7

4.6

344.83

351.57

umol/l

0.14

234

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

107

695

1.56

4.54

1.6

1.3

13.54

5.32

u/ml

0.33

126

(3048929) Epstein Barr virus Ab [Presence] in Serum

350

1.79

4.48

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2298

22162

1.28

4.45

6.2

6.5

2.54

2.64

mmol/l

6.12

2014

19898

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

209

2.03

4.42

1.8

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

243

1852

1.34

4.40

8.8

6.8

93.79

93.75

0.04

243

1845

(3020191) Ethanol [Moles/volume] in Serum or Plasma

100

2.51

4.38

1.2

1.3

0.74

0.83

promille

0.12

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

106

694

1.55

4.36

1.5

1.3

1.33

2.72

u/ml

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

231

1.96

4.35

1.2

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

421

1.71

4.34

1.1

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

537

1.62

4.32

1.4

1.2

788.16

547.59

mg/l

0.41

514

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

267

1.89

4.31

1.4

1.2

173.71

158.75

au/ml

0.32

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

171

2.12

4.29

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

602

1.58

4.26

1.2

1020.00

938.00

titre

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

114

2.38

4.23

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

153

2.17

4.18

2.1

1.6

6.76

8.80

mmol/l

3.25

153

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.90

4.13

1.3

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

135

2.24

4.08

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

238

1.91

4.02

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

169

2.09

4.02

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

386

1.70

3.98

1.2

1.4

29.13

30.88

g/l

0.46

354

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

297

1.80

3.96

1.4

1.7

25.14

24.92

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

138

2.19

3.89

1.3

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.46

3.88

1.1

1.3

103.96

137.67

mmol/24h

1.77

(43055514) Macroprolactin [Presence] in Serum or Plasma

7.29

3.86

1.5

1.1

—

(3021788) Differential panel - Synovial fluid

514

1.59

3.85

2.0

1.5

—

1.00

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2131

20453

1.22

3.84

4.4

4.5

1.20

1.27

mmol/l

6.79

1838

17902

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

179

2.03

3.84

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

179

2.03

3.84

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

174

2.03

3.74

2.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2239

21614

1.24

3.72

5.4

5.5

4.62

4.69

mmol/l

2.02

1963

19416

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

177

1322

1.36

3.69

1.4

1.3

78.07

52.73

au/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

109

2.31

3.68

2.0

2.28

1.96

u/field

0.08

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

239

1.86

3.65

1.4

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

176

2.00

3.64

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

183

1.98

3.63

1.3

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

467

1.60

3.62

1.2

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

397

1.65

3.62

2.7

2.1

27.22

23.95

mg/l

0.22

122

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

396

3296

1.24

3.61

5.0

5.4

36.83

34.76

2.54

224

1946

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

148

1078

1.40

3.60

2.1

2.9

142.90

1155.98

u/ml

0.99

123

908

(3007566) Smooth muscle Ab [Titer] in Serum

588

1.53

3.58

1.2

1.1

186.67

105.21

titre

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

234

1.85

3.56

1.1

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.58

3.55

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.82

3.52

4.8

2.0

4.06

5.25

ug/l

0.76

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

235

1.84

3.52

1.4

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

6.17

3.50

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.88

3.49

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

310

1.72

3.47

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

2.54

3.46

1.6

1.4

34.33

35.34

0.04

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

259

1.79

3.43

1.3

1.5

116.00

330.00

titre

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.01

3.37

2.3

1.6

15.34

18.87

umol/l

—

(3045142) Bone marrow Pathology biopsy report

268

1.77

3.37

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

391

1.63

3.32

1.2

0.18

0.20

nmol/l

0.64

310

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

124

890

1.41

3.30

1.5

1.6

36.54

24.74

u/ml

0.19

111

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.55

3.29

1.1

1.2

—

(3036489) Thrombin time

111

783

1.44

3.26

2.7

1.8

22.11

21.14

0.52

704

(3049717) Cytology report of Urine Cyto stain

109

767

1.44

3.24

2.2

2.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

249

1.78

3.24

1.2

3.72

4.26

u/ml

0.09

110

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

190

1467

1.32

3.20

2.6

2.5

39.84

26.06

au/ml

0.49

104

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

150

2.01

3.20

1.8

1.4

12.20

13.52

u/l

0.51

142

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

157

1.99

3.19

1.2

314.00

152.22

titre

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

258

1.76

3.18

1.2

4.33

3.40

u/ml

0.12

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.26

3.13

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.26

3.13

1.5

1.3

3.12

2.43

mmol/l

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.44

3.04

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.44

3.04

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

137

1016

1.37

3.03

3.8

3.5

0.90

0.83

nmol/l

0.54

109

837

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.55

2.95

1.1

1.0

627.09

257.10

pmol/l

0.37

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

541

1.49

2.94

3.2

2.2

222.21

213.38

0.31

509

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

258

1.72

2.91

3.0

3.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

756

6792

1.16

2.90

6.1

4.8

0.14

0.52

—

119

(3022621) pH of Urine by Test strip

273

2237

1.25

2.89

4.4

3.6

6.23

6.12

1.30

198

1594

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.26

2.86

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

252

1.72

2.85

2.1

2.3

2.27

1.62

u/field

0.40

121

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

116

2.08

2.82

2.1

1.5

0.12

0.15

nmol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

180

1.84

2.78

1.0

290.52

336.96

ng/l

0.67

117

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2208

21415

1.19

2.77

5.4

1.65

1.59

mmol/l

6.15

1931

19102

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

181

1.83

2.73

1.0

34.39

46.54

ng/l

1.33

119

(3004616) Nuclear Ab [Presence] in Serum

317

1.62

2.73

1.5

1.3

—

(3047189) Immunofixation for 24 hour Urine

118

2.04

2.71

1.3

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

2.70

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

197

1.79

2.68

1.3

1.1

4.81

2.31

eliau/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

522

1.47

2.62

1.5

1.2

70.95

45.32

u/ml

0.77

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

406

3497

1.19

2.62

10.9

8.1

—

(3011436) Histone Ab [Units/volume] in Serum

2.55

2.61

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.01

2.56

1.3

2.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

2.36

2.55

1.0

1.9

—

(3002619) Bacteria identified in Specimen by Culture

2.43

2.54

1.8

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.23

2.54

1.1

—

(40768446) Kidney Pathology biopsy report

2.61

2.53

1.6

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

306

2578

1.21

2.51

2.7

2.3

56.67

39.14

u/l

0.53

265

2142

(3024891) Influenza virus A+B Ag [Presence] in Specimen

496

1.46

2.47

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

342

1.56

2.46

1.3

1.4

3491.75

1610.47

e6/l

0.41

243

(3006442) Creatine [Moles/volume] in Serum or Plasma

123

1.96

2.45

2.0

1.6

67.67

76.61

umol/l

1.04

123

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

167

1.81

2.40

1.2

2.13

2.22

mmol/l

0.22

158

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

182

1.77

2.39

1.0

700.28

750.53

ng/l

0.19

118

(3027570) Oxalate [Moles/time] in 24 hour Urine

6.26

2.37

1.4

158.20

297.13

umol/24h

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.42

2.37

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

110

826

1.35

2.32

4.4

3.0

1.50

1.64

mmol/l

1.17

105

812

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.22

2.30

1.0

—

(3006270) Folate [Moles/volume] in Blood

253

1.63

2.30

1.2

313.59

339.80

nmol/l

0.32

210

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

163

1.79

2.27

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.11

2.22

1.0

1.2

58.67

62.79

ug/l

—

(3033099) Centromere Ab [Titer] in Serum

2.34

2.21

1.4

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

128

1.88

2.21

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.86

2.20

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

109

826

1.33

2.18

4.5

3.7

3.90

3.81

mmol/l

1.22

109

821

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.17

2.14

2.6

3.0

29.90

28.63

umol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

512

1.42

2.13

1.2

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.11

2.12

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.21

2.11

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

145

1.80

2.10

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

145

1.80

2.10

1.3

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

507

0.61

2.08

1.6

1.8

—

(4015189) Microbial culture of sputum

2.26

2.07

1.9

2.8

—

(40768443) Skin Pathology biopsy report

158

1269

1.26

2.06

1.4

1.2

—

(3016879) Cocaine [Presence] in Urine

103

1.95

2.05

1.2

—

(21494755) Public health laboratory ask at order entry panel

505

0.61

2.05

1.2

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

318

1.52

2.03

3.1

3.2

12.57

12.64

index

0.02

149

(3024932) HLA-DR beta [Type]

3.08

2.01

1.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

148

1.76

1.98

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

960

0.72

1.97

1.8

2.0

3.02

3.26

ratio

1.10

781

(44806071) Cardiolipin IgM antibody measurement

3.34

1.96

1.1

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.08

1.96

1.3

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

479

1.41

1.95

1.1

1.4

—

(3024471) HLA-A [Type]

2.97

1.93

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.97

1.93

1.1

1.0

—

(4195642) Thrombophilia screening test

234

1.59

1.93

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

242

1.58

1.93

1.2

1.3

196.24

249.08

u/l

0.68

230

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

688

0.68

1.92

1.6

1.8

3.40

3.50

mmol/l

0.20

497

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.06

1.90

3.4

2.1

0.60

0.61

mmol/l

0.55

(3034891) Synovial lining cells/cells in Synovial fluid

121

1.83

1.88

2.2

1.5

1.60

2.25

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.19

1.88

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

237

1.57

1.84

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

190

1.64

1.84

1.2

1.1

—

5.37

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.17

1.77

1.1

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.23

1.74

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

238

2035

1.19

1.72

4.1

4.4

50.10

102.44

u/ml

2.60

230

1954

(3038515) Glucose [Moles/volume] in Venous blood

709

1.31

1.70

4.7

3.1

7.17

7.86

mmol/l

1.69

699

(3034426) Prothrombin time (PT)

2.30

1.70

1.0

1.3

30.36

27.93

0.26

(4198724) Urine methamphetamine measurement

3.16

1.66

1.0

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

112

1.79

1.64

1.3

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.44

1.64

1.6

2.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.44

1.64

1.5

—

(3028300) Cannabinoids [Presence] in Urine

113

1.78

1.60

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.07

1.59

1.3

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

239

1.51

1.57

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

348

1.42

1.54

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.43

1.53

1.8

2.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

265

1.48

1.53

1.2

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

124

1.70

1.47

1.2

1.3

—

(3045788) Cell count panel - Pleural fluid

285

1.45

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.13

1.44

4.2

6.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

1.97

1.43

1.1

1.3

10.50

14.12

g/l

—

(3024869) Neuronal Ab [Presence] in Serum

2.31

1.43

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

212

1830

1.17

1.41

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

119

1.69

1.37

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

1.4

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.87

1.34

1.1

1535.57

1751.55

miu/ml

0.31

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

786

0.76

1.33

1.5

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

105

1.72

1.33

1.2

1.0

—

(3027008) Opiates [Presence] in Urine

113

1.69

1.31

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.81

1.31

1.1

36.00

479.78

ng/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

174

2025

0.85

1.30

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.30

1.0

1.1

—

(4212803) Bone marrow aspirate examination

2.50

1.30

1.3

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

106

1.70

1.29

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.89

1.28

1.5

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.09

1.27

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.94

1.27

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

288

2566

1.14

1.26

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

178

1.52

1.26

1.3

1.2

9.15

10.01

u/l

0.20

157

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

204

0.54

1.26

1.1

1.2

6.55

8.01

mmol/l

—

161

(3038177) Helicobacter pylori Ab [Presence] in Serum

278

1.41

1.24

1.2

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

2.40

1.24

1.3

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

717

1.25

1.23

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

214

0.56

1.21

1.1

1.2

1.62

1.65

g/l

0.10

214

(4035726) Immunohistochemistry procedure

280

2501

1.13

1.19

1.4

—

(3027944) Amphetamines [Presence] in Urine

109

1.66

1.18

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.71

1.17

1.1

1.2

136.25

135.86

nmol/l

0.01

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.93

1.17

1.7

1.4

1.19

1.18

mmol/l

0.10

(3023511) Choriogonadotropin [Units/volume] in Urine

2.05

1.15

1.0

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.50

1.15

1.0

—

(3028433) Virus identified in Specimen by Culture

1.81

1.15

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.65

1.06

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

271

1.37

1.04

1.3

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

297

1.35

1.04

1.2

1.4

211733.53

46896.91

e6/l

0.36

157

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.28

1.03

24.6

17.5

4.70

4.35

mmol/l

—

(3002256) Pathology report gross observation

355

3247

1.11

1.03

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.06

1.03

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

1.57

0.99

1.1

—

(44806420) Estimation of glomerular filtration rate

188

0.58

0.99

2.0

2.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.95

0.97

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

329

0.70

0.95

1.1

—

(4133840) Spirometry

2.22

0.93

2.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

118

1.53

0.90

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

102

1.57

0.90

1.3

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.00

0.87

1.0

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

230

1.35

0.84

1.3

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.94

0.84

1.0

1.1

0.04

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

283

1.31

0.83

1.1

1.2

221.22

220.05

miu/ml

—

(40768804) Tissue Pathology biopsy report

1042

10038

1.06

0.82

2.4

2.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.88

0.81

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

172

1.40

0.81

1.6

2.3

7.06

7.00

mmol/l

0.03

112

(4268621) Lupus anticoagulant assay

181

1.38

0.80

2.5

2.2

—

(3016750) Collection duration of Urine

114

1.49

0.79

2.4

1.9

535.75

492.78

min

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.82

0.79

1.8

1.2

11.98

9.56

pmol/l

—

(3008898) HLA-B27 [Presence]

492

1.22

0.79

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.67

0.78

1.1

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.53

0.78

1.3

1.2

38.82

40.95

g/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

115

1.48

0.76

1.1

307.64

275.45

mg/l

0.19

(3029634) Reagin Ab [Titer] in Serum by VDRL

157

1.40

0.76

1.5

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

107

1.50

0.76

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

302

0.73

0.75

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.64

0.75

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

0.74

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.09

0.74

4.2

5.8

9.94

10.01

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.09

0.74

8.2

6.2

—

(40757373) Influenza virus identified in Isolate

1.64

0.73

1.7

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.00

0.72

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

580

1.19

0.72

5.9

3.9

18.23

26.42

mg/l

2.60

419

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.80

0.72

2.0

1.3

—

(3005570) Glucose [Moles/volume] in Urine

308

1.27

0.72

2.2

2.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

117

1.46

0.71

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1.62

0.71

1.1

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

168

1.37

0.71

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

126

1.43

0.70

1.7

1.3

70.98

49.78

u/l

0.72

107

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

101

1.49

0.70

1.2

1.0

1.09

1.31

u/l

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

400

1.23

0.69

1.3

—

(3024263) Appearance of Synovial fluid

135

1.41

0.69

2.5

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.64

0.68

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

213

1.32

0.68

1.5

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

1.51

0.66

1.4

1.2

0.54

0.52

ratio

—

(3000330) Specific gravity of Urine by Test strip

179

1627

1.11

0.65

5.5

4.1

1.02

ratio

0.15

158

1466

(3014765) Yersinia sp identified in Stool by Organism specific culture

774

1.16

0.64

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

251

1.28

0.64

1.2

1.1

—

(3001729) Color of Synovial fluid

1.67

0.61

2.4

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

778

1.15

0.61

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

380

1.21

0.60

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

122

1.40

0.60

1.1

52.73

40.18

mg/l

0.20

106

(40768806) Pleura Pathology biopsy report

272

1.25

0.59

1.1

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.54

0.59

1.3

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

381

1.21

0.59

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

114

1.41

0.58

2.4

3.8

1.03

1.43

0.59

114

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.56

0.58

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

219

0.73

0.57

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

126

1133

1.12

0.57

1.0

1.1

—

(4034850) Laboratory test

764

1.14

0.57

16.2

11.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

764

1.14

0.57

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

928

8994

1.05

0.56

4.1

3.9

13.98

8.05

mg/mmol

1.34

534

5034

(3005988) Vibrio sp identified in Specimen by Organism specific culture

384

1.20

0.55

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.54

0.55

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.54

0.55

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.54

0.55

1.9

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.54

0.55

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.54

0.55

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.54

0.55

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

394

1.20

0.55

1.3

—

(3020650) Glucose [Presence] in Urine

1.47

0.54

3.8

2.1

0.00

0.04

estimate

0.49

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.42

0.54

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

213

1.27

0.54

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

368

1.20

0.53

2.0

1.5

0.81

0.80

nmol/l

0.06

295

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

187

1.29

0.52

1.3

1.1

88.62

95.36

0.72

172

(3035320) C reactive protein [Mass/volume] in Body fluid

196

1.28

0.52

3.4

3.1

36.79

27.20

mg/l

0.38

147

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

217

2018

1.08

0.51

2.9

2.6

55.60

58.66

ml/min/173m2

0.70

110

922

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.47

0.50

1.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.46

0.50

1.0

1.1

—

(3012516) Albumin [Mass/volume] in Urine

907

8814

1.04

0.49

3.4

3.2

45.94

35.50

mg/l

0.60

528

5090

(40768441) Liver Pathology biopsy report

163

1.29

0.48

1.7

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

835

1.12

0.46

7.5

5.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

366

1.18

0.45

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

201

1.25

0.45

4.2

5.0

158.66

43.13

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1.40

0.44

1.3

7.74

63.52

u/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.40

0.44

1.6

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.61

0.43

4.2

7.7

4.60

5.45

kpa

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

397

1.16

0.42

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

509

0.86

0.41

3.4

1.7

2.96

5.21

mg/l

1.09

403

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(1002224) Polysomnography panel

530

0.87

0.41

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

834

1.11

0.40

1.3

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.02

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.40

0.35

1.3

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

172

1.22

0.34

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

605

0.89

0.34

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

173

1.22

0.33

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

192

1.20

0.32

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

408

1.13

0.31

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

140

1.22

0.27

5.1

6.1

75.37

14.55

ug/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.25

0.27

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

149

0.80

0.25

1.2

1.3

—

(3000285) Sodium [Moles/volume] in Blood

0.74

0.24

1.5

1.3

135.83

137.52

mmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.32

0.23

1.2

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.28

0.23

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.25

0.22

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.27

0.22

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.31

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

64.30

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.8

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

101

0.79

0.21

11.0

4.1

13.56

13.54

—

101

(3004775) Volume in Urine collected for unspecified duration

154

1.17

0.21

2.3

2.1

684.00

626.09

—

100

(4281824) Cell count and differential, peritoneal fluid

421

1.09

0.21

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

512

0.92

0.21

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

177

0.85

0.21

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.20

0.0

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.20

0.19

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.15

0.19

1.0

1.8

16.33

12.58

mm/h

—

(3025130) Human papilloma virus identified in Specimen

280

0.89

0.18

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.18

0.16

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

139

1.15

0.16

1.4

1.8

—

(40765096) Chromosome analysis panel by Banding

1.13

0.16

1.3

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.20

0.16

1.7

1.8

258.83

914.65

e6/l

—

(40768793) Breast Pathology biopsy report

100

1045

0.96

0.15

1.3

1.4

—

(44813793) Dust mix specific IgE antibody measurement

149

0.87

0.13

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

179

0.89

0.12

1.4

1.3

—

(4146454) Self-monitoring of blood glucose

312

0.93

0.11

3.0

2.8

—

(3006462) Nitrate [Presence] in Urine

124

1.13

0.11

4.3

5.0

—

(1761868) Lipid panel - Serum or Plasma

616

6230

0.99

0.11

3.9

3.7

—

(3000034) Microalbumin [Mass/volume] in Urine

202

1.09

0.10

2.9

2.6

26.83

19.21

mg/l

0.16

136

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

212

1.09

0.10

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

154

1.10

0.10

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

154

1.10

0.10

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

961

1.03

0.09

1.4

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

126

1.11

0.09

1.4

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.82

0.07

1.3

1.4

4.87

5.55

mmol/l

—

(3044007) Cell count panel - Peritoneal fluid

0.86

0.07

1.6

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.87

0.07

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

423

4191

1.01

0.06

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

955

9583

0.99

0.04

2.1

1.9

1.21

1.31

mmol/l

4.96

755

7776

(4211845) Urine protein measurement

132

1.06

0.02

4.3

4.8

—

(3023410) Appearance of Cerebral spinal fluid

207

0.97

0.01

1.4

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

1.04

0.00

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

265

0.98

0.00

1.1

1.13

110.11

iu/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

202

0.99

0.00

1.2

1.1

0.28

0.64

u/ml

—

114

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

492

1.00

0.00

2.8

2.1

84.22

64.30

ug/min

0.19

261

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1745

17448

1.00

0.00

44.0

25.9

328.06

328.98

g/l

3.97

1739

17304

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

57.87

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

-0.00

0.0

2.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

16.8

—

112.20

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.95

-0.00

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.5

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.94

-0.00

13.7

11.1

0.60

0.64

mmol/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.0

—

4.37

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.97

-0.00

1.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3021.80

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint OSTPOPATFRCTURE_POSTEMENO and mortality.

Females

Parameter	HR [95% CI]	p-value
OSTPOPATFRCTURE_POSTEMENO	1.727 [1.55, 1.92]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.258

During the follow-up period (1.1.1998 — 31.12.2019), 8086 out of 16030 females with OSTPOPATFRCTURE_POSTEMENO died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have OSTPOPATFRCTURE_POSTEMENO.

N-year risk	Females	Males
1	0.188%	No data
5	0.901%	No data
10	2.339%	No data
15	4.592%	No data
20	8.454%	No data

Relationships between endpoints

↥

Index endpoint: OSTPOPATFRCTURE_POSTEMENO – Postmenopausal osteoporosis with pathological fracture

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Postmenopausal osteoporosis with pathological fracture

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints